"Brand_name","Drug_name_original","Drug_name","DrugId","targetId","targetId_type","Sponsor","Properties","TA","Indication","Indication_cur","diseaseId","diseaseId_type","Disease_class","Year.x","Review_type","has_GE","Year.y","Interactor","Related","Interactor_Related"
"Accrufer","Ferric maltol","FERRIC MALTOL","CHEMBL4298110",NA,"Original","Shield Therapeutics","Iron replacement product","No human target","Iron deficiency anaemia","iron deficiency anemia","HP_0001891","Original","Not serious",2019,"S",NA,NA,NA,NA,NA
"Adakveo","Crizanlizumab","CRIZANLIZUMAB","CHEMBL4297734","ENSG00000174175","Original","Novartis","P-selectin blocker","Other indication","Painful complications of SCD","sickle cell disease and related diseases","MONDO_0017146","Original","Serious",2019,"P, O, B",FALSE,2019,FALSE,FALSE,FALSE
"Adbry","Tralokinumab","Tralokinumab","CHEMBL1743081","ENSG00000169194","Original","LEO Pharma","IL-13-targeted mAb","Other indication","Atopic dermatitis","atopic eczema","EFO_0000274","Original","Not serious",2021,"S",TRUE,2021,FALSE,FALSE,FALSE
"Addyi","Flibanserin","FLIBANSERIN","CHEMBL231068","ENSG00000178394, ENSG00000102468, ENSG00000069696","Original","Sprout","Serotonin receptor modulator","Other indication","Hypoactive sexual desire disorder","sexual dysfunction","EFO_0004714","Original","Not serious",2015,"S",FALSE,2015,FALSE,FALSE,FALSE
"Adempas","Riociguat","RIOCIGUAT","CHEMBL2107834","ENSG00000123201, ENSG00000164116, ENSG00000061918, ENSG00000152402","Original","Bayer","Soluble guanylyl cyclase stimulator","Other indication","Persistent or recurrent chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension","pulmonary arterial hypertension","EFO_0001361","Original","Serious",2013,"P, O",TRUE,2013,FALSE,FALSE,FALSE
"Adlyxin","Lixisenatide","LIXISENATIDE","CHEMBL2108336","ENSG00000112164","Original","Sanofi","GLP1 receptor agonist","Other indication","Diabetes","diabetes mellitus","EFO_0000400","Original","Not concordant",2016,"S",TRUE,2016,FALSE,FALSE,FALSE
"Aduhelm","Aducanumab","Aducanumab","CHEMBL3039540","ENSG00000142192","Original","Biogen/Eisai","Amyloid-beta-targeted mAb","Other indication","Alzheimers disease","Alzheimers disease","MONDO_0004975","Original","Serious",2021,"P, A, F",TRUE,2021,FALSE,FALSE,FALSE
"Aemcolo","Rifamycin","RIFAMYCIN","CHEMBL437765",NA,"Original","Cosmo Technologies","Ansamycin antibacterial","No human target","Travellers diarrhoea","Diarrhea","HP_0002014","Original","Not serious",2018,"P, F",NA,NA,NA,NA,NA
"Aimovig","Erenumab","ERENUMAB","CHEMBL3833329","ENSG00000064989","Original","Amgen/Novartis","CGRP receptor antibody","Other indication","Migraine","migraine disorder","MONDO_0005277","Original","Not serious",2018,"S",TRUE,2018,TRUE,FALSE,FALSE
"Ajovy","Fremanezumab","FREMANEZUMAB","CHEMBL4297756","ENSG00000110680, ENSG00000175868","Original","Teva","CGRP antibody","Other indication","Migraine","migraine disorder","MONDO_0005277","Original","Not serious",2018,"P",TRUE,2018,FALSE,FALSE,FALSE
"Aklief","Trifarotene","TRIFAROTENE","CHEMBL3707313","ENSG00000172819","Original","Galderma","Retinoic acid receptor agonist","Other indication","Acne vulgaris","acne","EFO_0003894","Original","Not serious",2019,"S",FALSE,2019,FALSE,FALSE,FALSE
"Akynzeo","Netupitant; palonosetron","NETUPITANT; PALONOSETRON","CHEMBL206253; CHEMBL1189679","ENSG00000115353; ENSG00000166736","Original","Helsinn","An NK1-receptor antagonist plus a 5-HT3-receptor antagonist","Other indication","Chemotherapy-related nausea","Chemotherapy-induced nausea and vomiting","EFO_0006911","Original","Not serious",2014,"S",FALSE,2014,FALSE,FALSE,FALSE
"Akynzeo IV","Palonosetron; fosnetupitant","PALONOSETRON; FOSNETUPITANT","CHEMBL1189679; CHEMBL3989917","ENSG00000166736; ENSG00000115353","Original","Helsinn Group","5-HT3-receptor antagonist and NK1-receptor antagonist","Other indication","Chemotherapy-induced emesis","Chemotherapy-induced nausea and vomiting","EFO_0006911","Original","Not serious",2018,"S",FALSE,2018,FALSE,FALSE,FALSE
"Alecensa","Alectinib","ALECTINIB","CHEMBL1738797","ENSG00000171094, ENSG00000143924, ENSG00000165731","Original","Roche","ALK inhibitor","Oncology","NSCLC","non-small cell lung carcinoma","EFO_0003060","Original","Serious",2015,"P, O, B, A",TRUE,2015,FALSE,FALSE,FALSE
"Aliqopa","Copanlisib dihydrochloride","COPANLISIB","CHEMBL3218576","ENSG00000171608, ENSG00000121879","Original","Bayer","PI3Kalpha/‚Äö√¢√†‚àö‚â†¬¨¬®‚Äö√Ñ¬¢ inhibitor","Oncology","Follicular lymphoma","follicular lymphoma","MONDO_0018906","Original","Serious",2017,"P, O, A, F",TRUE,2017,FALSE,TRUE,FALSE
"Alunbrig","Brigatinib","BRIGATINIB","CHEMBL3545311","ENSG00000171094, ENSG00000146648","Original","Ariad Pharmaceuticals/Takeda","ALK inhibitor","Oncology","ALK-positive NSCLC","non-small cell lung carcinoma","EFO_0003060","Original","Serious",2017,"P, O, B, A",TRUE,2017,FALSE,FALSE,FALSE
"Amondys 45","Casimersen","Casimersen","CHEMBL4297566","ENSG00000198947","Original","Sarepta","Exon 45-skipping ASO","Other indication","DMD","Duchenne muscular dystrophy","MONDO_0010679","Original","Serious",2021,"P, O, A, F",TRUE,2021,FALSE,FALSE,FALSE
"Amvuttra","Vutrisiran","Vutrisiran","CHEMBL4594511","ENSG00000118271","Original","Alnylam","TTR-targeted siRNA","Other indication","Polyneuropathy of hereditary TTR-mediated amyloidosis","familial amyloid neuropathy","EFO_0004129","Original","Serious",2022,"S, O, F",TRUE,2022,FALSE,FALSE,FALSE
"Annovera","Segesterone acetate; ethinyl estradiol","SEGESTERONE ACETATE; ETHINYL ESTRADIOL","CHEMBL3707377; CHEMBL691","ENSG00000082175; ENSG00000091831","Original","TherapeuticsMD","Progestin and estrogen combined hormonal contraceptive","Other indication","Female contraception","contraception","EFO_0009520","Original","Not serious",2018,"S",TRUE,2018,FALSE,FALSE,FALSE
"Anoro Ellipta","Umeclidinium; vilanterol","UMECLIDINIUM; VILANTEROL","CHEMBL1187833; CHEMBL1198857","ENSG00000133019; ENSG00000169252","Original","GSK","Anticholinergic and a LABA","Other indication","Chronic obstructive pulmonary disease","chronic obstructive pulmonary disease","EFO_0000341","Original","Serious",2013,"S",TRUE,2013,FALSE,FALSE,FALSE
"Anthim","Obiltoxaximab","OBILTOXAXIMAB","CHEMBL3544926",NA,"Original","Elusys Therapeutics","mAb against anthrax toxin","No human target","Anthrax","anthrax infection","EFO_0000778","Original","Serious",2016,"S, O, F",NA,NA,NA,NA,NA
"Aptiom","Eslicarbazepine","ESLICARBAZEPINE","CHEMBL315985","ENSG00000168356, ENSG00000169432, ENSG00000144285, ENSG00000007314, ENSG00000136546, ENSG00000185313, ENSG00000136531, ENSG00000183873, ENSG00000196876, ENSG00000153253","Original","Sunovion","MOA unknown, but thought to involve voltage-gated sodium channels","Other indication","Partial-onset seizures","Seizure","HP_0001250","Original","Not concordant",2013,"S",TRUE,2013,FALSE,FALSE,FALSE
"Aristada","Aripiprazole lauroxil","ARIPIPRAZOLE LAUROXIL","CHEMBL2219425","ENSG00000102468, ENSG00000178394, ENSG00000149295","Original","Alkermes","Extended release atypical antipsychotic","Other indication","Schizophrenia","schizophrenia","MONDO_0005090","Original","Not concordant",2015,"S",TRUE,2015,FALSE,FALSE,FALSE
"Artesunate","Artesunate","ARTESUNATE","CHEMBL361497",NA,"Original","Amivas","Artemisinin antimalarial","No human target","Serious malaria","malaria","EFO_0001068","Original","Serious",2020,"P, O, B, F",NA,NA,NA,NA,NA
"Asparlas","Calaspargase pegol","CALASPARGASE PEGOL","CHEMBL2108728","ENSG00000166183","Original","Servier","Asparagine specific enzyme","Oncology","ALL","acute lymphoblastic leukemia","EFO_0000220","Original","Serious",2018,"S, O",FALSE,2018,FALSE,FALSE,FALSE
"Austedo","Deutetrabenazine","DUTETRABENAZINE","CHEMBL3137326","ENSG00000165646","Original","Teva","VMAT2 inhibitor","Other indication","Chorea associated with Huntington disease","chorea; Huntington disease","EFO_0004152; MONDO_0007739","Original","Serious",2017,"S, O",TRUE,2017,FALSE,FALSE,FALSE
"Avycaz","Avibactam; ceftazidime","AVIBACTAM; CEFTAZIDIME","CHEMBL1689063; CHEMBL44354","NA; NA","Original","Allergan","A beta-lactamase inhibitor and a cephalosporin","No human target","Complicated intra-abdominal infections and complicated urinary tract infections","infection","EFO_0000544","Original","Serious",2015,"P, F",NA,NA,NA,NA,NA
"Axumin","Fluciclovine F-18","FLUCICLOVINE F-18","CHEMBL3707267","ENSG00000155465, ENSG00000105281, ENSG00000165349","Original","Blue Earth","Radioactive diagnostic","Other indication","Suspected prostate cancer recurrence","prostate cancer","MONDO_0008315","Original","Serious",2016,"P",TRUE,2016,FALSE,FALSE,FALSE
"Ayvakit","Avapritinib","AVAPRITINIB","CHEMBL4204794","ENSG00000157404, ENSG00000134853","Original","Blueprint Medicines","PDGFRA, PDGFRA mutants and KIT kinase inhibitor","Oncology","GIST with PDGFRA exon 18 mutations","gastrointestinal stromal tumor","MONDO_0011719","Original","Serious",2020,"P, O, B, F",TRUE,2020,FALSE,FALSE,FALSE
"Azstarys","Dexmethylphenidate; serdexmethylphenidate","Dexmethylphenidate; serdexmethylphenidate","CHEMBL827; CHEMBL4301162","ENSG00000103546, ENSG00000142319; ENSG00000142319, ENSG00000103546","Original","Commave Therapeutics","CNS stimulant","Other indication","ADHD","attention deficit hyperactivity disorder","EFO_0003888","Original","Not serious",2021,"S",TRUE,2021,FALSE,FALSE,FALSE
"Balversa","Erdafitinib","ERDAFITINIB","CHEMBL3545376","ENSG00000077782, ENSG00000066468, ENSG00000160867, ENSG00000068078","Original","Janssen /J&J","FGFR inhibitor","Oncology","Bladder cancer","urinary bladder carcinoma","MONDO_0004986","Original","Serious",2019,"P, B, A",TRUE,2019,FALSE,FALSE,FALSE
"Barhemsys","Amisulpride","AMISULPRIDE","CHEMBL243712","ENSG00000151577, ENSG00000149295, ENSG00000164270, ENSG00000157219, ENSG00000158748, ENSG00000166736, ENSG00000186090, ENSG00000178084, ENSG00000102468, ENSG00000149305, ENSG00000179097, ENSG00000135914, ENSG00000178394, ENSG00000168830, ENSG00000147246, ENSG00000186038, ENSG00000148680, ENSG00000135312, ENSG00000179546","Original","Acacia","Dopamine receptors D2 & D3 antagonist","Other indication","Nausea and vomiting after surgery","Nausea and vomiting","HP_0002017","Original","Not serious",2020,"S",FALSE,2020,FALSE,FALSE,FALSE
"Bavencio","Avelumab","AVELUMAB","CHEMBL3833373","ENSG00000120217","Original","Merck KGaA/Pfizer","PDL1-blocking antibody","Oncology","Merkel cell carcinoma","Merkel cell skin cancer","EFO_1001471","Original","Serious",2017,"P, O, B, A, F",TRUE,2017,FALSE,FALSE,FALSE
"Baxdela","Delafloxacin","DELAFLOXACIN","CHEMBL2105637",NA,"Original","Melinta Therapeutics","Fluoroquinolone antibacterial","No human target","Acute bacterial skin and skin structure infections","staphylococcal skin infections","EFO_1001849","Original","Not serious",2017,"P, F",NA,NA,NA,NA,NA
"Beleodaq","Belinostat","BELINOSTAT","CHEMBL408513","ENSG00000108840, ENSG00000147099, ENSG00000061273, ENSG00000068024, ENSG00000171720, ENSG00000094631, ENSG00000163517, ENSG00000048052, ENSG00000100429, ENSG00000196591, ENSG00000116478","Original","Spectrum","Histone-deacetylase inhibitor","Other indication","Peripheral T-cell lymphoma","unspecified peripheral T-cell lymphoma","EFO_0000211","Original","Serious",2014,"P, O, A, F",TRUE,2014,TRUE,FALSE,FALSE
"Belsomra","Suvorexant","SUVOREXANT","CHEMBL1083659","ENSG00000137252, ENSG00000121764","Original","Merck & Co.","Orexin-receptor antagonist","Other indication","Insomnia","insomnia","EFO_0004698","Original","Not serious",2014,"S",TRUE,2014,FALSE,TRUE,FALSE
"Benznidazole","Benznidazole","BENZNIDAZOLE","CHEMBL110",NA,"Original","Chemo Research","Nitroimidazole antimicrobial","No human target","Chagas disease","Chagas disease","MONDO_0001444","Original","Serious",2017,"P, O, A",NA,NA,NA,NA,NA
"Beovu","Brolucizumab","BROLUCIZUMAB","CHEMBL3707357","ENSG00000112715","Original","Novartis","VEGF inhibitor","Other indication","Wet age-related macular degeneration","macular degeneration","EFO_0009606","Original","Not concordant",2019,"S",TRUE,2019,FALSE,FALSE,FALSE
"Besponsa","Inotuzumab ozogamicin","INOTUZUMAB OZOGAMICIN","CHEMBL2108611","ENSG00000012124","Original","Pfizer","CD22-directed antibody‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚àö√´‚Äö√†√∂¬¨¬Ædrug conjugate","Oncology","B cell precursor ALL","precursor B-cell acute lymphoblastic leukemia","MONDO_0020511","Original","Serious",2017,"P, O, B",TRUE,2017,FALSE,TRUE,FALSE
"Besremi","Ropeginterferon alfa-2b","Ropeginterferon alfa-2b","CHEMBL4297819","ENSG00000142166, ENSG00000159110","Original","Pharmaessentia","PEGylated interferon alpha-2b","Oncology","Polycythaemia vera","polycythemia vera","EFO_0002429","Original","Serious",2021,"S, O",TRUE,2021,TRUE,FALSE,FALSE
"Bevyxxa","Betrixaban","BETRIXABAN","CHEMBL512351","ENSG00000126218","Original","Portola Pharmaceuticals","FXa inhibitor","Other indication","Prophylaxis of venous thromboembolism","venous thromboembolism","EFO_0004286","Original","Serious",2017,"P, F",TRUE,2017,FALSE,FALSE,FALSE
"Biktarvy","Bictegravir; emtricitabine; tenofovir alafenamide","BICTEGRAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE","CHEMBL3989866; CHEMBL885; CHEMBL2107825","NA; NA; NA","Original","Gilead Sciences","HIV-1 integrase inhibitor and HIV-1 nucleoside/nucleotide reverse transcriptase inhibitors","No human target","HIV","hiv infection","EFO_0000764","Original","Serious",2018,"P",NA,NA,NA,NA,NA
"Blenrep","Belantamab mafodotin","BELANTAMAB MAFODOTIN","CHEMBL4298209","ENSG00000048462, ENSG00000152086, ENSG00000167553, ENSG00000188229, ENSG00000137267, ENSG00000176014, ENSG00000261456, ENSG00000127824, ENSG00000123416, ENSG00000137285, ENSG00000258947, ENSG00000167552, ENSG00000198033, ENSG00000196230, ENSG00000104833, ENSG00000101162","Original","GlaxoSmithKline","BCMA-directed ADC, with microtubule inhibitor","Oncology","Multiple myeloma","multiple myeloma","EFO_0001378","Original","Serious",2020,"P, O, B, A",TRUE,2020,FALSE,FALSE,FALSE
"Blincyto","Blinatumomab","BLINATUMOMAB","CHEMBL1742992","ENSG00000177455, ENSG00000160654, ENSG00000167286, ENSG00000198851","Original","Amgen","CD19- and CD3-bispecific antibody","Oncology","B-ALL","precursor B-cell acute lymphoblastic leukemia","MONDO_0020511","Original","Serious",2014,"P, O, B, A",TRUE,2014,FALSE,TRUE,FALSE
"Braftovi","Encorafenib","ENCORAFENIB","CHEMBL3301612","ENSG00000157764","Original","Array BioPharma","BRAF inhibitor","Oncology","BRAF-mutated melanoma","melanoma","EFO_0000756","Original","Serious",2018,"S, O",TRUE,2018,FALSE,FALSE,FALSE
"Breo Ellipta","Fluticasone; vilanterol","FLUTICASONE; VILANTEROL","CHEMBL1473; CHEMBL1198857","ENSG00000113580; ENSG00000169252","Original","GSK","Corticosteroid plus LABA","Other indication","Chronic obstructive pulmonary disease","chronic obstructive pulmonary disease","EFO_0000341","Original","Serious",2013,"S",TRUE,2013,FALSE,FALSE,FALSE
"Brexafemme","Ibrexafungerp","Ibrexafungerp","CHEMBL4297513",NA,"Original","Scynexis","Triterpenoid antifungal","No human target","Vulvovaginal candidiasis",NA,NA,"Original",NA,2021,"P, F",NA,NA,NA,NA,NA
"Bridion","Sugammadex","SUGAMMADEX","CHEMBL2111107",NA,"Original","Merck & Co.","A modified gamma cyclodextrin","No human target","Reversal of neuromuscular blockade during surgery","neuromuscular disease","EFO_1001902","Original","Serious",2015,"P",NA,NA,NA,NA,NA
"Brineura","Cerliponase alfa","CERLIPONASE ALFA","CHEMBL3544921","ENSG00000166340","Original","BioMarin Pharmaceutical","Tripeptidyl peptidase","Other indication","Tripeptidyl peptidase 1 deficiency (neuronal ceroid lipofuscinosis type 2*)","neuronal ceroid lipofuscinosis 2","MONDO_0008769","Original","Serious",2017,"P, O, B",TRUE,2017,FALSE,FALSE,FALSE
"Brintellix","Vortioxetine","VORTIOXETINE","CHEMBL2104993","ENSG00000178394, ENSG00000108576, ENSG00000166736","Original","Takeda","Serotonin reuptake inhibitor","Other indication","Major depressive disorder","major depressive disorder","MONDO_0002009","Original","Not serious",2013,"S",TRUE,2013,FALSE,FALSE,FALSE
"Briumvi","Ublituximab","Ublituximab","CHEMBL2108354","ENSG00000156738","Original","TG Therapeutics","CD20-targeted mAb","Other indication","Relapsing forms of multiple sclerosis","relapsing-remitting multiple sclerosis","EFO_0003929","Original","Serious",2022,"S",FALSE,2022,FALSE,FALSE,FALSE
"Briviact","Brivaracetam","BRIVARACETAM","CHEMBL607400","ENSG00000159164, ENSG00000144285","Original","UCB","Anticonvulsant with unknown MOA, binds to SV2A","Other indication","Partial-onset seizures","Focal-onset seizure","HP_0007359","Original","Not concordant",2016,"S",TRUE,2016,FALSE,FALSE,FALSE
"Brukinsa","Zanubrutinib","ZANUBRUTINIB","CHEMBL3936761","ENSG00000010671","Original","BeiGene","BTK inhibitor","Oncology","Mantle cell lymphoma","mantle cell lymphoma","EFO_1001469","Original","Serious",2019,"P, O, B, A, F",TRUE,2019,FALSE,FALSE,FALSE
"Byfavo","Remimazolam","REMIMAZOLAM","CHEMBL4297526","ENSG00000102287, ENSG00000163288, ENSG00000186297, ENSG00000145864, ENSG00000113327, ENSG00000011677, ENSG00000094755, ENSG00000163285, ENSG00000151834, ENSG00000109158, ENSG00000268089, ENSG00000187730, ENSG00000182256, ENSG00000022355, ENSG00000145863, ENSG00000166206","Original","Acacia","Benzodiazepine","Other indication","Procedural sedation","sedation","EFO_0009868","Original","Not serious",2020,"S",TRUE,2020,FALSE,TRUE,FALSE
"Bylvay","Odevixibat","Odevixibat","CHEMBL4297588","ENSG00000125255","Original","Albireo","IBAT inhibitor","Other indication","Pruritus in PFIC","familial intrahepatic cholestasis","MONDO_0017290","Original","Serious",2021,"P, O, F",TRUE,2021,FALSE,FALSE,FALSE
"Cabenuva Kit","Cabotegravir; rilpivirine","Cabotegravir; rilpivirine","CHEMBL2403238; CHEMBL175691","NA; NA","Original","ViiV","INSTI and an NNRTI","No human target","HIV-1 infection",NA,NA,"Original",NA,2021,"P, F",NA,NA,NA,NA,NA
"Cablivi","Caplacizumab","CAPLACIZUMAB","CHEMBL2109624","ENSG00000110799","Original","Sanofi/Ablynx","vWF-directed nanobody","Other indication","ATTP","thrombotic thrombocytopenic purpura","MONDO_0018896","Original","Serious",2019,"P, O, F",TRUE,2019,TRUE,FALSE,FALSE
"Calquence","Acalabrutinib","ACALABRUTINIB","CHEMBL3707348","ENSG00000010671","Original","AstraZeneca/Acerta Pharma","BTK inhibitor","Oncology","Mantle cell lymphoma","Mantle cell lymphoma","EFO_1001469","Original","Serious",2017,"P, O, B, A",TRUE,2017,FALSE,FALSE,FALSE
"Camzyos","Mavacamten","Mavacamten","CHEMBL4297517","ENSG00000092054","Original","Bristol Myers Squibb","Cardiac myosin inhibitor","Other indication","Classes of obstructive HCM (Hypertrophic Obstructive Cardiomyopathy)","hypertrophic cardiomyopathy","EFO_0000538","Original","Serious",2022,"S, O, B",TRUE,2022,FALSE,FALSE,FALSE
"Caplyta","Lumateperone","LUMATEPERONE","CHEMBL3306803","ENSG00000102468, ENSG00000108576, ENSG00000149295","Original","Intra-Cellular Therapies","Atypical antipsychotic","Other indication","Schizophrenia","schizophrenia","MONDO_0005090","Original","Not concordant",2019,"S, F",TRUE,2019,FALSE,FALSE,FALSE
"Cerdelga","Eliglustat","ELIGLUSTAT","CHEMBL2110588","ENSG00000148154","Original","Genzyme","Glucosylceramide-synthase inhibitor","Other indication","Gaucher's disease","Gaucher disease","MONDO_0018150","Original","Serious",2014,"P, O",FALSE,2014,FALSE,FALSE,FALSE
"Cholbam","Cholic acid","CHOLIC ACID","CHEMBL205596",NA,"Original","Retrophin","A primary bile acid","No human target","Bile acid synthesis disorders and peroxisomal disorders","peroxisomal disease; Disorder of bile acid synthesis","MONDO_0019053; Orphanet_79168","Original","Serious",2015,"P, O",NA,NA,NA,NA,NA
"Cibinqo","Abrocitinib","Abrocitinib","CHEMBL3655081","ENSG00000162434","Original","Pfizer","JAK inhibitor","Other indication","Atopic dermatitis","atopic eczema, Eczema","EFO_0000274; HP_0000964","Original","Not serious",2022,"P, B",TRUE,2022,TRUE,TRUE,TRUE
"Cinqair","Reslizumab","RESLIZUMAB","CHEMBL2107884","ENSG00000113525","Original","Teva","IL-5 antagonist","Other indication","Serious asthma","Status Asthmaticus","EFO_0008590","Original","Serious",2016,"S",TRUE,2016,FALSE,TRUE,FALSE
"Copiktra","Duvelisib","DUVELISIB","CHEMBL3039502","ENSG00000105851, ENSG00000171608","Original","Verastem","PI3K inhibitor","Oncology","CLL, FL and SLL","chronic lymphocytic leukemia; follicular lymphoma","EFO_0000095; MONDO_0018906","Original","Serious",2018,"P, O, A, F",TRUE,2018,TRUE,TRUE,FALSE
"Copper dotatate Cu-64","Copper dotatate Cu-64","COPPER DOTATATE CU-64","CHEMBL4297339","ENSG00000180616","Original","Radiomedix","Radioactive diagnostic","Other indication","Imaging, cancer","neuroendocrine neoplasm","EFO_1001901","Original","Serious",2020,"P, O, F",TRUE,2020,TRUE,FALSE,FALSE
"Corlanor","Ivabradine","IVABRADINE","CHEMBL471737","ENSG00000138622","Original","Amgen","Hyperpolarization-activated cyclic nucleotide-gated channel blocker","Other indication","Chronic heart failure","congestive heart failure","EFO_0000373","Original","Serious",2015,"P, F",TRUE,2015,FALSE,FALSE,FALSE
"Cosela","Trilaciclib","Trilaciclib","CHEMBL3894860","ENSG00000135446, ENSG00000105810","Original","G1 Therapeutics","CDK4 and CDK6 kinase inhibitor","Oncology","Chemotherapy-induced myelosuppression","myelosuppression; small cell lung carcinoma","EFO_0007053; EFO_0000702","Original","Serious",2021,"P, B",TRUE,2021,FALSE,FALSE,FALSE
"Cosentyx","Secukinumab","SECUKINUMAB","CHEMBL1743068","ENSG00000112115","Original","Novartis","IL-17A antagonist","Other indication","Plaque psoriasis, *psoriatic arthritis, ankylosing spondylitis, along with other joint inflammatory disorders.","psoriasis vulgaris","EFO_1001494","Original","Not serious",2015,"S",FALSE,2015,FALSE,FALSE,FALSE
"Cotellic","Cobimetinib","COBIMETINIB","CHEMBL2146883","ENSG00000126934, ENSG00000169032","Original","Genentech","MEK inhibitor","Oncology","Melanoma with BRAFV600E/K mutations","melanoma","EFO_0000756","Original","Serious",2015,"P, O, F",TRUE,2015,FALSE,FALSE,FALSE
"Cresemba","Isavuconazonium","ISAVUCONAZONIUM","CHEMBL1183349",NA,"Original","Astellas","Azole antifungal","No human target","Antifungal","aspergillosis; mucormycosis","EFO_0007157; EFO_0007380","Original","Serious",2015,"P, O",NA,NA,NA,NA,NA
"Crysvita","Burosumab","BUROSUMAB","CHEMBL3707326","ENSG00000118972","Original","Ultragenyx Pharmaceutical/Kyowa Hakko Kirin","FGF23 antibody","Other indication","X-linked hypophosphataemia","Hypophosphatemia","HP_0002148","Original","Not serious",2018,"P, O, B, F",TRUE,2018,FALSE,FALSE,FALSE
"Cyramza","Ramucirumab","RAMUCIRUMAB","CHEMBL1743062","ENSG00000128052","Original","Eli Lilly","VEGFR2 antagonist","Oncology","Gastric cancer","gastric cancer","MONDO_0001056","Original","Serious",2014,"P, O, F",TRUE,2014,FALSE,FALSE,FALSE
"Cytalux","Pafolacianine","Pafolacianine","CHEMBL4297412","ENSG00000110195","Original","On Target Labs","Fluorescent FR imaging agent","Other indication","Ovarian cancer imaging","ovarian carcinoma","EFO_0001075","Original","Serious",2021,"P, O, F",FALSE,2021,FALSE,FALSE,FALSE
"Daklinza","Daclatasvir","DACLATASVIR","CHEMBL2023898",NA,"Original","Bristol-Myers Squibb","NS5A inhibitor","No human target","HCV","hepatitis C virus infection","EFO_0003047","Original","Serious",2015,"P, F",NA,NA,NA,NA,NA
"Dalvance","Dalbavancin","DALBAVANCIN","CHEMBL3301669",NA,"Original","Durata","Semisynthetic lipoglycopeptide","No human target","ABSSSI (Acute Bacterial Skin and Skin Structure Infections)","staphylococcal skin infections","EFO_1001849","Original","Not serious",2014,"P, F",NA,NA,NA,NA,NA
"Danyelza","Naxitamab","NAXITAMAB","CHEMBL4297984",NA,"Original","Y-mAbs Therapeutics","GD2-directed mAb",NA,"High-risk neuroblastoma","neuroblastoma","EFO_0000621","Original","Serious",2020,"P, O, B, A",NA,NA,NA,NA,NA
"Darzalex","Daratumumab","DARATUMUMAB","CHEMBL1743007","ENSG00000004468","Original","Johnson & Johnson","CD38-directed mAb","Oncology","Multiple myeloma","multiple myeloma","EFO_0001378","Original","Serious",2015,"P, O, B, A, F",TRUE,2015,FALSE,TRUE,FALSE
"Daurismo","Glasdegib","GLASDEGIB","CHEMBL2043437","ENSG00000128602","Original","Pfizer","Hedgehog pathway inhibitor","Oncology","AML","acute myeloid leukemia","EFO_0000222","Original","Serious",2018,"P, O",TRUE,2018,FALSE,FALSE,FALSE
"Daxxify","DaxibotulinumtoxinA","DaxibotulinumtoxinA","CHEMBL3707359","ENSG00000132639","Original","Revance","Botulinum toxin","Other indication","Glabellar lines","Facial wrinkling","HP_0009762","Original","Not serious",2022,"S",FALSE,2022,FALSE,FALSE,FALSE
"Dayvigo","Lemborexant","LEMBOREXANT","CHEMBL3545367","ENSG00000121764, ENSG00000137252","Original","Eisai","Orexin receptor antagonist","Other indication","Insomnia","insomnia","EFO_0004698","Original","Not serious",2019,"S",TRUE,2019,FALSE,TRUE,FALSE
"Defitelio","Defibrotide sodium","DEFIBROTIDE SODIUM","CHEMBL3707226","ENSG00000122194","Original","Gentium","Profibrinolytic","Other indication","Hepatic veno-occlusive disease","hepatic veno-occlusive disease","MONDO_0019514","Original","Serious",2016,"P, O, F",TRUE,2016,FALSE,TRUE,FALSE
"Diacomit","Stiripentol","STIRIPENTOL","CHEMBL1983350","ENSG00000022355","Original","Biocodex","GABA reuptake inhibitor","Other indication","Dravet syndrome","dravet syndrome","Orphanet_33069","Original","Serious",2018,"P, O",TRUE,2018,FALSE,FALSE,FALSE
"Dojolvi","Triheptanoin","TRIHEPTANOIN","CHEMBL4297585",NA,"Original","Ultragenyx","Medium-chain triglyceride","No human target","LC-FAODs","inherited fatty acid metabolism disorder","MONDO_0037858","Original","Serious",2020,"S, O, F",NA,NA,NA,NA,NA
"Doptelet","Avatrombopag","AVATROMBOPAG","CHEMBL2103883","ENSG00000117400","Original","Dova Pharmaceuticals","Thrombopoietin receptor agonist","Other indication","Thrombocytopenia","thrombocytopenia","HP_0001873","Original","Not concordant",2018,"P",TRUE,2018,FALSE,FALSE,FALSE
"Dotarem","Gadoterate meglumine","GADOTERATE MEGLUMINE","CHEMBL2219415",NA,"Original","Guerbet","Gadolinium-based contrast agent","No human target","Contrast agent to visualize disruption of the blood-brain barrier",NA,NA,"Original",NA,2013,"P",NA,NA,NA,NA,NA
"Duavee","Bazedoxifene acetate; oestrogens","BAZEDOXIFENE ACETATE; ESTROGENS, CONJUGATED","CHEMBL2106615; CHEMBL1201649","ENSG00000091831, ENSG00000140009; ENSG00000140009, ENSG00000091831","Original","Pfizer","Conjugated oestrogens with an oestrogen receptor modulator","Other indication","Moderate to Serious vasomotor symptoms associated with menopause and prevention of postmenopausal osteoporosis","menopause; postmenopausal osteoporosis","EFO_0003922; EFO_0003854","Original","Not serious",2013,"S",TRUE,2013,TRUE,FALSE,FALSE
"Dupixent","Dupilumab","DUPILUMAB","CHEMBL2108675","ENSG00000077238","Original","Regeneron/Sanofi","IL-4Ralpha antagonist","Other indication","Atopic dermatitis","atopic eczema","EFO_0000274","Original","Not serious",2017,"P, B",TRUE,2017,FALSE,FALSE,FALSE
"Ebanga","Ansuvimab","ANSUVIMAB","CHEMBL4594388",NA,"Original","Ridgeback","Ebola glycoprotein-directed mAb","No human target","Ebola virus","Ebola hemorrhagic fever","EFO_0007243","Original","Serious",2020,"P, O, B",NA,NA,NA,NA,NA
"Egaten","Triclabendazole","TRICLABENDAZOLE","CHEMBL1086440",NA,"Original","Novartis","Anthelmintic","No human target","Fascioliasis","fascioliasis","EFO_1001324","Original","Not concordant",2019,"P, O, F",NA,NA,NA,NA,NA
"Elahere","Mirvetuximab soravtansine","Mirvetuximab soravtansine","CHEMBL3545132","ENSG00000110195, ENSG00000127824, ENSG00000152086, ENSG00000261456, ENSG00000101162, ENSG00000188229, ENSG00000104833, ENSG00000258947, ENSG00000123416, ENSG00000198033, ENSG00000167553, ENSG00000137285, ENSG00000167552, ENSG00000176014, ENSG00000137267, ENSG00000196230","Original","ImmunoGen","FR_-targeted antibody-drug conjugate","Oncology","Ovarian cancer","ovarian carcinoma","EFO_0001075","Original","Serious",2022,"P, O, A, F",TRUE,2022,TRUE,FALSE,FALSE
"Elucirem","Gadopiclenol","Gadopiclenol","CHEMBL4297634",NA,"Original","Guerbet","Gadolinium-based contrast agent","No human target","Lesions with abnormal vascularity",NA,NA,"Original",NA,2022,"P",NA,NA,NA,NA,NA
"Elzonris","Tagraxofusp","TAGRAXOFUSP","CHEMBL4297573","ENSG00000167658, ENSG00000185291","Original","Stemline Therapeutics","IL-3 and diphtheria toxin fusion protein","Oncology","Blastic plasmacytoid dendritic cell neoplasm","blastic plasmacytoid dendritic cell neoplasm","EFO_0010580","Original","Serious",2018,"P, O, B",FALSE,2018,FALSE,FALSE,FALSE
"Emflaza","Deflazacort","DEFLAZACORT","CHEMBL1201891","ENSG00000113580","Original","PTC Therapeutics","Corticosteroid","Other indication","Duchenne muscular dystrophy","Duchenne muscular dystrophy","MONDO_0010679","Original","Serious",2017,"P, O, F",FALSE,2017,FALSE,FALSE,FALSE
"Emgality","Galcanezumab","GALCANEZUMAB","CHEMBL3707328","ENSG00000175868, ENSG00000110680","Original","Eli Lilly","CGRP antibody","Other indication","Migraine","migraine disorder","MONDO_0005277","Original","Not serious",2018,"S, F",TRUE,2018,FALSE,FALSE,FALSE
"Empaveli","Pegcetacoplan","Pegcetacoplan","CHEMBL4298211","ENSG00000125730","Original","Apellis","Complement protein C3 inhibitor","Other indication","PNH","paroxysmal nocturnal hemoglobinuria","MONDO_0100244","Original","Serious",2021,"P, O, F",TRUE,2021,TRUE,FALSE,FALSE
"Empliciti","Elotuzumab","ELOTUZUMAB","CHEMBL1743010","ENSG00000026751","Original","Bristol-Myers Squibb","SLAMF7-directed mAb","Oncology","Multiple myeloma","multiple myeloma","EFO_0001378","Original","Serious",2015,"P, O, B",TRUE,2015,TRUE,FALSE,FALSE
"Enhertu","Trastuzumab deruxtecan","TRASTUZUMAB DERUXTECAN","CHEMBL4297844","ENSG00000141736, ENSG00000198900","Original","Daiichi Sankyo/AstraZeneca","HER2-directed ADC","Oncology","HER2-positive breast cancer","HER2 Positive Breast Carcinoma","EFO_1000294","Original","Serious",2019,"P, B, A, F",TRUE,2019,FALSE,FALSE,FALSE
"Enjaymo","Sutimlimab","Sutimlimab","CHEMBL4297832","ENSG00000182326","Original","Bioverativ","C1s-targeted mAb","Other indication","RBC transfusion due to haemolysis in CAD (cold agglutinin disease)","Anemia, Hemolytic, Autoimmune","EFO_1001264","Original","Serious",2022,"P, O, B",FALSE,2022,FALSE,FALSE,FALSE
"Enspryng","Satralizumab","SATRALIZUMAB","CHEMBL3833307","ENSG00000160712, ENSG00000134352","Original","Roche/Genentech","IL-6R-directed mAb","Other indication","NMOSD","neuromyelitis optica","EFO_0004256","Original","Serious",2020,"S, O, B, F",TRUE,2020,FALSE,TRUE,FALSE
"Entresto","Sacubitril; valsartan","SACUBITRIL; VALSARTAN","CHEMBL3137301; CHEMBL1069","ENSG00000196549; ENSG00000144891","Original","Novartis","A neprilysin inhibitor plus an angiotensin II receptor blocker","Other indication","Chronic heart failure","congestive heart failure","EFO_0000373","Original","Serious",2015,"P, F",TRUE,2015,TRUE,FALSE,FALSE
"Entyvio","Vedolizumab","VEDOLIZUMAB","CHEMBL1743087","ENSG00000115232, ENSG00000139626","Original","Takeda","Integrin-receptor antagonist","Other indication","Ulcerative colitis and Crohn's disease","ulcerative colitis; Crohn's disease","EFO_0000729; EFO_0000384","Original","Serious",2014,"P, F",TRUE,2014,FALSE,FALSE,FALSE
"Epclusa","Sofosbuvir; velpatasvir","SOFOSBUVIR; VELPATASVIR","CHEMBL1259059; CHEMBL3545062","NA; NA","Original","Gilead Sciences","A nucleotide analogue NS5B polymerase inhibitor plus an HCV NS5A inhibitor","No human target","genotype 1, 2, 3 or 4 chronic hepatitis C virus (HCV)","hepatitis C virus infection","EFO_0003047","Original","Serious",2016,"P, B, F",NA,NA,NA,NA,NA
"Epidiolex","Cannabidiol","CANNABIDIOL","CHEMBL190461","ENSG00000118432","Original","GW Pharmaceuticals","Cannabinoid","Other indication","Dravet syndrome and Lennox-Gastaut syndrome","Dravet syndrome; Lennox-Gastaut syndrome","Orphanet_33069; MONDO_0016532","Original","Serious",2018,"P, O, F",TRUE,2018,FALSE,TRUE,FALSE
"Erleada","Apalutamide","APALUTAMIDE","CHEMBL3183409","ENSG00000169083","Original","Johnson & Johnson","Androgen receptor inhibitor","Oncology","Prostate cancer","prostate cancer","MONDO_0008315","Original","Serious",2018,"P, F",TRUE,2018,FALSE,FALSE,FALSE
"Esbriet","Pirfenidone","PIRFENIDONE","CHEMBL1256391",NA,"Original","InterMune","MOA unknown","No human target","IPF (idiopathic pulmonary fibrosis)","idiopathic pulmonary fibrosis","EFO_0000768","Original","Serious",2014,"P, O, B, F",NA,NA,NA,NA,NA
"Eucrisa","Crisaborole","CRISABOROLE","CHEMBL484785","ENSG00000184588, ENSG00000113448, ENSG00000065989, ENSG00000105650","Original","Pfizer/Anacor Pharmaceuticals","PDE4 inhibitor","Other indication","Atopic dermatitis","atopic eczema","EFO_0000274","Original","Not serious",2016,"S",TRUE,2016,FALSE,TRUE,FALSE
"Evenity","Romosozumab","ROMOSOZUMAB","CHEMBL2107874","ENSG00000167941","Original","Amgen","Sclerostin inhibitor","Other indication","Osteoporosis","osteoporosis","EFO_0003882","Original","Not serious",2019,"S",TRUE,2019,FALSE,FALSE,FALSE
"Evkeeza","Evinacumab","Evinacumab","CHEMBL3545191","ENSG00000132855","Original","Regeneron","ANGPTL3-targeted mAb","Other indication","HoFH","homozygous familial hypercholesterolemia","MONDO_0018328","Original","Serious",2021,"P, O, B",TRUE,2021,FALSE,FALSE,FALSE
"Evrysdi","Risdiplam","RISDIPLAM","CHEMBL4297528","ENSG00000205571","Original","Roche/Genentech","SMN2 splicing modifier","Other indication","Spinal muscular atrophy","spinal muscular atrophy","EFO_0008525","Original","Serious",2020,"P, O, F",TRUE,2020,FALSE,FALSE,FALSE
"ExEm Foam","Air polymer-type A","AIR POLYMER-TYPE A","CHEMBL4594264",NA,"Original","Giskit","Ultrasound contrast agent","No human target","Assess fallopian tube patency in women with known or suspected infertility","infertility","EFO_0000545","Original","Not serious",2019,"S",NA,NA,NA,NA,NA
"Exkivity","Mobocertinib","Mobocertinib","CHEMBL4650319","ENSG00000146648","Original","Takeda","EGFR kinase inhibitor","Oncology","EGFR exon 20-mutated NSCLC","non-small cell lung carcinoma","EFO_0003060","Original","Serious",2021,"P, O, B, A, F",TRUE,2021,FALSE,FALSE,FALSE
"Exondys 51","Eteplirsen","ETEPLIRSEN","CHEMBL2108278","ENSG00000198947","Original","Sarepta Therapeutics","ASO designed to target dystrophin pre-mRNA","Other indication","Duchenne muscular dystrophy","Duchenne muscular dystrophy","MONDO_0010679","Original","Serious",2016,"P, O, A, F",TRUE,2016,FALSE,FALSE,FALSE
"Farxiga","Dapagliflozin","DAPAGLIFLOZIN","CHEMBL429910","ENSG00000140675","Original","AstraZeneca","SGLT2 inhibitor","Other indication","Type 2 diabetes","type 2 diabetes mellitus","MONDO_0005148","Original","Not concordant",2014,"S, F",TRUE,2014,FALSE,TRUE,FALSE
"Farydak","Panobinostat","PANOBINOSTAT","CHEMBL483254","ENSG00000100429, ENSG00000196591, ENSG00000163517, ENSG00000061273, ENSG00000068024, ENSG00000048052, ENSG00000116478, ENSG00000108840, ENSG00000094631, ENSG00000171720, ENSG00000147099","Original","Novartis","Histone deacetylase inhibitor","Oncology","Multiple myeloma","multiple myeloma","EFO_0001378","Original","Serious",2015,"P, O, A",TRUE,2015,FALSE,FALSE,FALSE
"Fasenra","Benralizumab","BENRALIZUMAB","CHEMBL1742991","ENSG00000091181","Original","AstraZeneca","IL-5Ralpha-directed monoclonal antibody","Other indication","Serious asthma","Status Asthmaticus","EFO_0008590","Original","Serious",2017,"S",FALSE,2017,FALSE,FALSE,FALSE
"Fetroja","Cefiderocol","CEFIDEROCOL","CHEMBL3989974",NA,"Original","Shionogi","Cephalosporin antibacterial","No human target","Complicated urinary tract infections","urinary tract infection","EFO_0003103","Original","Not serious",2019,"P, F",NA,NA,NA,NA,NA
"Fexinidazole","Fexinidazole","Fexinidazole","CHEMBL1631694",NA,"Original","Sanofi/DNDi","Nitroimidazole antimicrobial","No human target","Sleeping sickness",NA,NA,"Original",NA,2021,"P, O",NA,NA,NA,NA,NA
"Firdapse","Amifampridine","AMIFAMPRIDINE","CHEMBL354077","ENSG00000130037, ENSG00000182255, ENSG00000173826, ENSG00000111262, ENSG00000178342, ENSG00000131398, ENSG00000140015, ENSG00000055118, ENSG00000168418, ENSG00000143473, ENSG00000183960, ENSG00000151079, ENSG00000184408, ENSG00000116396, ENSG00000171126, ENSG00000168263, ENSG00000026559, ENSG00000170745, ENSG00000185760, ENSG00000135519, ENSG00000184156, ENSG00000075043, ENSG00000117013, ENSG00000158445, ENSG00000166006, ENSG00000129159, ENSG00000124134, ENSG00000156486, ENSG00000143105, ENSG00000182674, ENSG00000053918, ENSG00000089558, ENSG00000177301, ENSG00000162975, ENSG00000102057, ENSG00000184611, ENSG00000171385, ENSG00000177272, ENSG00000104848, ENSG00000164794","Original","Catalyst Pharmaceuticals","Potassium channel blocker","Other indication","Lambert-Eaton myasthenic syndrome","Lambert-Eaton myasthenic syndrome","Orphanet_43393","Original","Serious",2018,"P, O",FALSE,2018,FALSE,FALSE,FALSE
"Flortaucipir F-18","Flortaucipir F-18","FLORTAUCIPIR F-18","CHEMBL3545253","ENSG00000186868","Original","Eli Lilly","Radioactive diagnostic","Other indication","Imaging, tau in Alzheimer disease","Alzheimer disease","MONDO_0004975","Original","Serious",2020,"P",TRUE,2020,FALSE,FALSE,FALSE
"Fluorodopa F-18","Fluorodopa F-18","FLUORODOPA F-18","CHEMBL3400972",NA,"Original","Feinstein Institutes","Radioactive diagnostic","No human target","Diagnosis of parkinsonian syndromes","Parkinson disease","MONDO_0005180","Original","Serious",2019,"S",NA,NA,NA,NA,NA
"Fluoroestradiol F-18","Fluoroestradiol F-18","FLUOROESTRADIOL F-18","CHEMBL4594261","ENSG00000186868","Original","Zionexa","Radioactive diagnostic","Other indication","Imaging, breast cancer","breast carcinoma","EFO_0000305","Original","Serious",2020,"S",TRUE,2020,FALSE,FALSE,FALSE
"Fotivda","Tivozanib","Tivozanib","CHEMBL1289494","ENSG00000102755, ENSG00000128052, ENSG00000037280, ENSG00000157404, ENSG00000113721","Original","Aveo","VEGFR kinase inhibitor","Oncology","Renal cell carcinoma","renal cell carcinoma","EFO_0000681","Original","Serious",2021,"S",TRUE,2021,FALSE,FALSE,FALSE
"Galafold","Migalastat","MIGALASTAT","CHEMBL110458","ENSG00000102393","Original","Amicus Therapeutics","beta-galactosidase regulator","Other indication","Fabry disease","fabry disease","MONDO_0010526","Original","Serious",2018,"P, O, A, F",TRUE,2018,FALSE,FALSE,FALSE
"Gallium dotatoc Ga-68","Gallium dotatoc Ga-68","GALLIUM DOTATOC GA-68","CHEMBL4297340","ENSG00000180616","Original","UIHC PET Imaging Center","Radioactive diagnostic","Other indication","Localization of somatostatin receptor-positive neuroendocrine tumours","neuroendocrine neoplasm","EFO_1001901","Original","Serious",2019,"S, O",TRUE,2019,TRUE,FALSE,FALSE
"Gamifant","Emapalumab","EMAPALUMAB","CHEMBL3989977","ENSG00000111537","Original","Novimmune","Interferon-‚Äö√¢√†‚àö‚â†‚Äö√Ñ√∂‚àö¬¢‚Äö√Ñ¬¢-blocking antibody","Other indication","Primary haemophagocytic lymphohistiocytosis","genetic hemophagocytic lymphohistiocytosis","MONDO_0015541","Original","Serious",2018,"P, O, B",TRUE,2018,FALSE,FALSE,FALSE
"Gavreto","Pralsetinib","PRALSETINIB","CHEMBL4582651","ENSG00000170759, ENSG00000165731, ENSG00000108091","Original","Blueprint Medicines/Roche","RET kinase inhibitor","Oncology","RET fusion-positive NSCLC","non-small cell lung carcinoma","EFO_0003060","Original","Serious",2020,"P, O, B, A",TRUE,2020,FALSE,FALSE,FALSE
"Gazyva","Obinutuzumab","OBINUTUZUMAB","CHEMBL1743048","ENSG00000156738","Original","Genentech","Humanized CD20-specific monoclonal antibody","Oncology","Previously untreated chronic lymphocytic leukaemia","chronic lymphocytic leukemia","EFO_0000095","Original","Serious",2013,"P, O, B",TRUE,2013,TRUE,FALSE,FALSE
"Gemtesa","Vibegron","VIBEGRON","CHEMBL2107826","ENSG00000188778","Original","Urovant Sciences","Beta-3 adrenergic receptor agonist","Other indication","Overactive bladder","overactive bladder","EFO_1000781","Original","Not serious",2020,"S",FALSE,2020,FALSE,FALSE,FALSE
"Genvoya","Elvitegravir; cobicistat; emtricitabine; tenofovir","ELVITEGRAVIR; COBICISTAT; EMTRICITABINE; TENOFOVIR","CHEMBL204656; CHEMBL2095208; CHEMBL885; CHEMBL483","NA; ENSG00000160870, ENSG00000106258, ENSG00000160868, ENSG00000021461; NA; NA","Original","Gilead","An INSTI plus a CYP3A inhibitor plus two nucleoside analogue reverse transcriptase inhibitors","No human target","HIV","HIV infection","EFO_0000764","Original","Serious",2015,"S, F",NA,2015,FALSE,FALSE,FALSE
"Giapreza","Angiotensin II","ANGIOTENSIN II","CHEMBL408403","ENSG00000144891","Original","La Jolla Pharmaceutical Company","Synthetic human angiotensin","Other indication","Blood pressure in adults with septic or other distributive shock","septic shock; blood pressure","EFO_0006834; EFO_0004325","Original","Serious",2017,"P",TRUE,2017,TRUE,FALSE,FALSE
"Gilotrif","Afatinib","AFATINIB","CHEMBL1173655","ENSG00000141736, ENSG00000146648, ENSG00000178568","Original","Boehringer Ingelheim","EGFR (ERBB1), HER2 (ERBB2), and HER4 (ERRB4) kinase inhibitor","Oncology","First-line treatment of patients with metastatic NSCLC whose tumours have EGFR exon 19 deletions or exon 21 (L858R) substitution mutations as detected by an FDA-approved test","non-small cell lung carcinoma","EFO_0003060","Original","Serious",2013,"P, O, F",TRUE,2013,FALSE,FALSE,FALSE
"Givlaari","Givosiran","GIVOSIRAN","CHEMBL4297760","ENSG00000023330","Original","Alnylam","ALAS1-directed siRNA","Other indication","Acute hepatic porphyria","acute hepatic porphyria","Orphanet_95157","Original","Serious",2019,"P, O, B",FALSE,2019,FALSE,FALSE,FALSE
"Harvoni","Ledipasvir; sofosbuvir","LEDIPASVIR; SOFOSBUVIR","CHEMBL2374220; CHEMBL1259059","NA; NA","Original","Gilead Sciences","An NS5A inhibitor plus an HCV nucleotide-analogue NS5B-polymerase inhibitor","No human target","Genotype 1 HCV","hepatitis C virus infection","EFO_0003047","Original","Serious",2014,"P, B, F",NA,NA,NA,NA,NA
"Hemlibra","Emicizumab","EMICIZUMAB","CHEMBL3833393","ENSG00000126218, ENSG00000101981","Original","Roche/Genentech","Bispecific FIX and FX-directed antibody","Other indication","Haemophilia A","hemophilia A","MONDO_0010602","Original","Serious",2017,"P, O, B",TRUE,2017,FALSE,FALSE,FALSE
"Hetlioz","Tasimelteon","TASIMELTEON","CHEMBL2103822","ENSG00000134640, ENSG00000168412","Original","Vanda","Melatonin-receptor agonist","Other indication","Non-24-hour sleep-wake disorder","sleep-wake disorder","MONDO_0003406","Original","Not serious",2014,"P, O",TRUE,2014,FALSE,TRUE,FALSE
"Ibrance","Palbociclib","PALBOCICLIB","CHEMBL189963","ENSG00000135446, ENSG00000110092, ENSG00000105810","Original","Pfizer","CDK4 and CDK6 inhibitor","Oncology","ER-positive, HER2-negative advanced breast cancer","HER2 negative breast carcinoma","EFO_0009780","Original","Serious",2015,"P, B, A",TRUE,2015,FALSE,FALSE,FALSE
"Ibsrela","Tenapanor","TENAPANOR","CHEMBL3304485","ENSG00000066230","Original","Ardelyx","NHE3 inhibitor","Other indication","IBS with constipation","irritable bowel syndrome","EFO_0000555","Original","Not serious",2019,"S",FALSE,2019,FALSE,FALSE,FALSE
"Idhifa","Enasidenib mesylate","ENASIDENIB MESYLATE","CHEMBL3989931","ENSG00000182054","Original","Celgene/Agios","IDH2 inhibitor","Oncology","IDH2-mutated AML","acute myeloid leukemia","EFO_0000222","Original","Serious",2017,"P, O, F",TRUE,2017,FALSE,FALSE,FALSE
"Ilumya","Tildrakizumab","TILDRAKIZUMAB","CHEMBL2108681","ENSG00000110944, ENSG00000113302","Original","Sun Pharma","IL-23 antibody","Other indication","Plaque psoriasis","psoriasis vulgaris","EFO_1001494","Original","Not serious",2018,"S",TRUE,2018,FALSE,FALSE,FALSE
"Imbruvica","Ibrutinib","IBRUTINIB","CHEMBL1873475","ENSG00000010671","Original","Pharmacyclics","Bruton's tyrosine kinase inhibitor","Oncology","Mantle cell lymphoma","Mantle cell lymphoma","EFO_1001469","Original","Serious",2013,"P, O, B, F",TRUE,2013,FALSE,FALSE,FALSE
"Imcivree","Setmelanotide","SETMELANOTIDE","CHEMBL3301624","ENSG00000166603","Original","Rhythm","Melanocortin receptor 4 agonist","Other indication","Rare genetic diseases of obesity","Bardet-Biedl syndrome","MONDO_0015229","Original","Serious",2020,"P, O, B",TRUE,2020,FALSE,FALSE,FALSE
"Imfinzi","Durvalumab","DURVALUMAB","CHEMBL3301587","ENSG00000120217","Original","AstraZeneca","PDL1-blocking antibody","Oncology","Urothelial carcinoma","urothelial carcinoma","EFO_0008528","Original","Serious",2017,"P, B, A",TRUE,2017,FALSE,FALSE,FALSE
"Imjudo","Tremelimumab","Tremelimumab","CHEMBL2108658","ENSG00000163599","Original","AstraZeneca","CTLA4-targeted mAb","Oncology","Hepatocellular carcinoma","hepatocellular carcinoma","EFO_0000182","Original","Serious",2022,"S, O",TRUE,2022,TRUE,FALSE,FALSE
"Impavido","Miltefosine","MILTEFOSINE","CHEMBL125",NA,"Original","Knight","MOA unknown","No human target","Leishmaniasis","Leishmaniasis","EFO_0005044","Original","Not concordant",2014,"P, O, F",NA,NA,NA,NA,NA
"Ingrezza","Valbenazine","VALBENAZINE","CHEMBL2364639","ENSG00000165646","Original","Neurocrine Biosciences","VMAT2 inhibitor","Other indication","Tardive dyskinesia","movement disorder","EFO_0004280","Original","Not concordant",2017,"P, B, F",TRUE,2017,FALSE,FALSE,FALSE
"Inmazeb","Atoltivimab; odesivimab; maftivimab","ATOLTIVIMAB; ODESIVIMAB; MAFTIVIMAB","CHEMBL4298183; CHEMBL4298188; CHEMBL4298184","NA; NA; NA","Original","Regeneron","Cocktail of Ebola glycoprotein-directed mAbs","No human target","Ebola virus","Ebola hemorrhagic fever","EFO_0007243","Original","Serious",2020,"P, O, B",NA,NA,NA,NA,NA
"Inqovi","Cedazuridine; decitabine","CEDAZURIDINE; DECITABINE","CHEMBL3237547; CHEMBL1201129","ENSG00000158825; ENSG00000119772, ENSG00000130816","Original","Otsuka","Cytidine deaminase inhibitor; nucleoside metabolic inhibitor","Other indication","Myelodysplastic syndromes","myelodysplastic syndrome","EFO_0000198","Original","Serious",2020,"P, O",TRUE,2020,FALSE,FALSE,FALSE
"Inrebic","Fedratinib","FEDRATINIB","CHEMBL1287853","ENSG00000096968, ENSG00000122025","Original","Celgene/BMS","JAK2 and FLT3 inhibitor","Other indication","Myelofibrosis","myelofibrosis","MONDO_0044903","Original","Serious",2019,"P, O",TRUE,2019,FALSE,FALSE,FALSE
"Invokana","Canagliflozin","CANAGLIFLOZIN; CANAGLIFLOZIN","CHEMBL4594217; CHEMBL2048484","ENSG00000140675; ENSG00000140675","Original","Janssen","SGLT2 inhibitor","Other indication","Type 2 diabetes","type 2 diabetes mellitus","MONDO_0005148","Original","Not concordant",2013,"S",TRUE,2013,FALSE,TRUE,FALSE
"Isturisa","Osilodrostat","OSILODROSTAT","CHEMBL3099695","ENSG00000160882","Original","Recordati Rare Diseases","Cortisol synthesis inhibitor","Other indication","Cushing disease","Cushing syndrome","EFO_0003099","Original","Not concordant",2020,"S, O",TRUE,2020,FALSE,FALSE,FALSE
"Jardiance","Empagliflozin","EMPAGLIFLOZIN","CHEMBL2107830","ENSG00000140675","Original","Boehringer Ingelheim","SGLT2 inhibitor","Other indication","Type 2 diabetes","type 2 diabetes mellitus","MONDO_0005148","Original","Not concordant",2014,"S, F",TRUE,2014,FALSE,TRUE,FALSE
"Jemperli","Dostarlimab","Dostarlimab","CHEMBL4298124","ENSG00000188389","Original","GlaxoSmithKline","PD1-targeted mAb","Oncology","Endometrial cancer","endometrial cancer","MONDO_0011962","Original","Serious",2021,"P, B, A",TRUE,2021,FALSE,FALSE,FALSE
"Jeuveau","Prabotulinumtoxin A","PRABOTULINUMTOXIN A","CHEMBL4297229","ENSG00000132639","Original","Evolus","Acetylcholine release inhibitor and a neuromuscular blocking agent","Other indication","Glabellar lines associated with corrugator and/or procerus muscle activity","Facial wrinkling","HP_0009762","Original","Not serious",2019,"S",FALSE,2019,FALSE,FALSE,FALSE
"Jublia","Efinaconazole","EFINACONAZOLE","CHEMBL2103877",NA,"Original","Dow","Azole antifungal","No human target","Onychomycosis of the toenails","paronychia","EFO_0007421","Original","Not serious",2014,"S",NA,NA,NA,NA,NA
"Kadcyla","Ado-trastuzumab emtansine","TRASTUZUMAB EMTANSINE","CHEMBL1743082","ENSG00000167553, ENSG00000196230, ENSG00000137285, ENSG00000123416, ENSG00000176014, ENSG00000137267, ENSG00000101162, ENSG00000258947, ENSG00000261456, ENSG00000188229, ENSG00000104833, ENSG00000127824, ENSG00000198033, ENSG00000167552, ENSG00000152086, ENSG00000141736","Original","Genentech","HER2-targeted antibody and microtubule inhibitor conjugate","Oncology","HER2-positive metastatic breast cancer","HER2 Positive Breast Carcinoma","EFO_1000294","Original","Serious",2013,"P, F",TRUE,2013,FALSE,FALSE,FALSE
"Kanuma","Sebelipase alfa","SEBELIPASE ALFA","CHEMBL3039537","ENSG00000107798","Original","Alexion","Enzyme replacement therapy","Other indication","LAL deficiency","lysosomal acid lipase deficiency","MONDO_0010204","Original","Serious",2015,"P, O, B, F",TRUE,2015,FALSE,FALSE,FALSE
"Kengreal","Cangrelor","CANGRELOR","CHEMBL334966","ENSG00000169313","Original","Medicines Company","P2Y12 platelet inhibitor","Other indication","Myocardial infarction, repeat coronary revascularization, and stent thrombosis","myocardial infarction","EFO_0000612","Original","Serious",2015,"S",FALSE,2015,FALSE,FALSE,FALSE
"Kerendia","Finerenone","Finerenone","CHEMBL2181927","ENSG00000151623","Original","Bayer","Non-steroidal MR antagonist","Other indication","CKD with type 2 diabetes","chronic kidney disease","EFO_0003884","Original","Serious",2021,"P, F",TRUE,2021,FALSE,TRUE,FALSE
"Kerydin","Tavaborole","TAVABOROLE","CHEMBL443052",NA,"Original","Anacor","Oxaborole antifungal","No human target","Onychomycosis of the toenails","paronychia","EFO_0007421","Original","Not serious",2014,"S",NA,NA,NA,NA,NA
"Kevzara","Sarilumab","SARILUMAB","CHEMBL2108730","ENSG00000160712","Original","Sanofi/Regeneron","IL-6 receptor antagonist","Other indication","Rheumatoid arthritis","rheumatoid arthritis","EFO_0000685","Original","Serious",2017,"S",TRUE,2017,FALSE,FALSE,FALSE
"Keytruda","Pembrolizumab","PEMBROLIZUMAB","CHEMBL3137343","ENSG00000188389","Original","Merck & Co.","PD1-specific antibody","Oncology","Metastatic melanoma *and others (2021 approval)","metastatic melanoma","EFO_0002617","Original","Serious",2014,"P, O, B, A",FALSE,2014,FALSE,FALSE,FALSE
"Kimmtrak","Tebentafusp","Tebentafusp","CHEMBL4297990","ENSG00000185664","Original","Immunocore","gp100 peptide HLA _ CD3 bispecific T-cell engager","Oncology","Uveal melanoma","Uveal Melanoma","EFO_1000616","Original","Serious",2022,"P, O, B",FALSE,2022,FALSE,FALSE,FALSE
"Kisqali","Ribociclib","RIBOCICLIB","CHEMBL3545110","ENSG00000105810, ENSG00000135446","Original","Novartis","CDK4/6 inhibitor","Oncology","HR-positive, HER2-negative breast cancer","HER2 negative breast carcinoma","EFO_0009780","Original","Serious",2017,"P, B",TRUE,2017,TRUE,TRUE,FALSE
"Klisyri","Tirbanibulin","TIRBANIBULIN","CHEMBL571546","ENSG00000197122","Original","Athenex","Microtubule inhibitor","Other indication","Actinic keratosis","actinic keratosis","EFO_0002496","Original","Not serious",2020,"S",TRUE,2020,TRUE,TRUE,FALSE
"Korsuva","Difelikefalin","Difelikefalin","CHEMBL3989915","ENSG00000082556","Original","Cara Therapeutics","kappa-Opioid receptor agonist","Other indication","Pruritus associated with CKD","chronic kidney disease","EFO_0003884","Original","Serious",2021,"P, B",FALSE,2021,FALSE,FALSE,FALSE
"Koselugo","Selumetinib","SELUMETINIB","CHEMBL1614701","ENSG00000169032, ENSG00000126934","Original","AstraZeneca","MEK1/2 kinase inhibitor","Other indication","Neurofibromatosis type 1","neurofibromatosis type 1","MONDO_0018975","Original","Serious",2020,"P, O, B",TRUE,2020,FALSE,TRUE,FALSE
"Krazati","Adagrasib","Adagrasib","CHEMBL4594350","ENSG00000133703","Original","Mirati","KRAS-G12C inhibitor","Oncology","KRASG12C-mutated NSCLC","non-small cell lung carcinoma","EFO_0003060","Original","Serious",2022,"S, O, B, A, F",TRUE,2022,FALSE,FALSE,FALSE
"Krintafel","Tafenoquine","TAFENOQUINE","CHEMBL298470",NA,"Original","Medicines for Malaria Venture/GlaxoSmithKline","8-Aminoquinoline antimalarial","No human target","Plasmodium vivax malaria","Plasmodium vivax malaria","EFO_0007445","Original","Serious",2018,"P, O, B, F",NA,NA,NA,NA,NA
"Kybella","Deoxycholic acid","DEOXYCHOLIC ACID","CHEMBL406393",NA,"Original","Kythera","Cytolytic drug","No human target","Fat below the chin","body fat distribution","EFO_0004341","Original","Not serious",2015,"S",NA,NA,NA,NA,NA
"Kynamro","Mipomersen","MIPOMERSEN","CHEMBL2219536","ENSG00000084674","Original","Genzyme","Oligonucleotide inhibitor of apolipoprotein B100 synthesis","Other indication","Homozygous familial hypercholesterolaemia","homozygous familial hypercholesterolemia","MONDO_0018328","Original","Serious",2013,"S, O",TRUE,2013,FALSE,FALSE,FALSE
"Lampit","Nifurtimox","NIFURTIMOX","CHEMBL290960",NA,"Original","Bayer","Nitrofuran antiprotozoal","No human target","Chagas disease","chagas disease","MONDO_0001444","Original","Serious",2020,"P, O, A",NA,NA,NA,NA,NA
"Lartruvo","Olaratumab","OLARATUMAB","CHEMBL1743049","ENSG00000134853","Original","Eli Lilly","PDGFRalpha-blocking antibody","Oncology","Soft tissue sarcoma","soft tissue sarcoma","EFO_1001968","Original","Serious",2016,"P, O, B, A, F",TRUE,2016,FALSE,FALSE,FALSE
"Lenvima","Lenvatinib","LENVATINIB","CHEMBL1289601","ENSG00000037280, ENSG00000128052, ENSG00000102755","Original","Eisai","VEGFR inhibitor","Oncology","Thyroid cancer","thyroid cancer","MONDO_0002108","Original","Serious",2015,"P, O",TRUE,2015,FALSE,FALSE,FALSE
"Leqvio","Inclisiran","Inclisiran","CHEMBL3990033","ENSG00000169174","Original","Novartis/Alnylam","PCSK9-targeted siRNA","Other indication","HeFH or ASCVD","coronary atherosclerosis","MONDO_0021661","Original","Serious",2021,"S",TRUE,2021,FALSE,FALSE,FALSE
"Libtayo","Cemiplimab","CEMIPLIMAB","CHEMBL4297723","ENSG00000188389","Original","Regeneron/Sanofi","PD1 antibody","Oncology","CSCC, BCC(*), NSCLC(*)","cutaneous squamous cell carcinoma; basal cell carcinoma; non-small cell lung carcinoma","EFO_1001927; EFO_0004193; EFO_0003060","Original","Serious",2018,"P, B",TRUE,2018,TRUE,FALSE,FALSE
"Livmarli","Maralixibat","Maralixibat","CHEMBL363392","ENSG00000125255","Original","Mirum","IBAT inhibitor","Other indication","Pruritus in Alagille syndrome","Alagille syndrome","MONDO_0007318","Original","Serious",2021,"P, O, B",TRUE,2021,FALSE,TRUE,FALSE
"Livtencity","Maribavir","Maribavir","CHEMBL515408",NA,"Original","Takeda","CMV pUL97 kinase inhibitor","No human target","Post-transplant CMV infection",NA,NA,"Original",NA,2021,"P, O, B",NA,NA,NA,NA,NA
"Lokelma","Sodium zirconium cyclosilicate","SODIUM ZIRCONIUM CYCLOSILICATE","CHEMBL3301592",NA,"Original","AstraZeneca","Potassium binder","No human target","Hyperkalaemia","hyperkalemia","HP_0002153","Original","Not concordant",2018,"S",NA,NA,NA,NA,NA
"Lonsurf","Tipiracil; trifluridine","TIPIRACIL; TRIFLURIDINE","CHEMBL235668; CHEMBL1129","ENSG00000025708; ENSG00000176890","Original","Taiho","Thymidine phosphorylase inhibitor plus a nucleoside metabolic inhibitor","Oncology","Colorectal cancer","colorectal cancer","EFO_0005842","Original","Serious",2015,"S, F",TRUE,2015,FALSE,FALSE,FALSE
"Lorbrena","Lorlatinib","LORLATINIB","CHEMBL3286830","ENSG00000171094, ENSG00000143924","Original","Pfizer","ALK and ROS1 inhibitor","Oncology","ALK-positive NSCLC","non-small cell lung carcinoma","EFO_0003060","Original","Serious",2018,"P, O, B, A",TRUE,2018,FALSE,FALSE,FALSE
"Lucemyra","Lofexidine","LOFEXIDINE","CHEMBL17860","ENSG00000150594, ENSG00000274286, ENSG00000184160","Original","US WorldMeds","beta2-adrenoceptor agonist","Other indication","Opioid withdrawal","opioid dependence","EFO_0005611","Original","Not serious",2018,"P, F",FALSE,2018,FALSE,FALSE,FALSE
"Lumakras","Sotorasib","Sotorasib","CHEMBL4535757","ENSG00000133703","Original","Amgen","KRAS-G12C inhibitor","Oncology","KRASG12C-mutated NSCLC","non-small cell lung carcinoma","EFO_0003060","Original","Serious",2021,"P, O, B, A, F",TRUE,2021,FALSE,FALSE,FALSE
"Lumason","Sulfur hexafluoride lipid-type A microspheres","SULFUR HEXAFLUORIDE LIPID-TYPE A MICROSPHERES",NA,NA,"Original","Bracco","Ultrasound contrast agent","No human target","Cardiovascular imaging",NA,NA,"Original",NA,2014,"S",NA,NA,NA,NA,NA
"Lumoxiti","Moxetumomab pasudotox","MOXETUMOMAB PASUDOTOX","CHEMBL1743043","ENSG00000167658, ENSG00000012124","Original","AstraZeneca","CD22-directed antibody‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚àö√´‚Äö√†√∂¬¨¬Ædrug conjugate","Oncology","Hairy cell leukaemia","hairy cell leukemia","EFO_1000956","Original","Serious",2018,"P, O, F",TRUE,2018,TRUE,FALSE,FALSE
"Lunsumio","Mosunetuzumab","Mosunetuzumab","CHEMBL4297788","ENSG00000167286, ENSG00000156738, ENSG00000198851, ENSG00000160654","Original","Roche/Genentech","CD20 _ CD3 bispecific antibody","Oncology","Follicular lymphoma","follicular lymphoma","MONDO_0018906","Original","Serious",2022,"P, O, B, A",TRUE,2022,FALSE,TRUE,FALSE
"Lupkynis","Voclosporin","Voclosporin","CHEMBL2218919","ENSG00000138814","Original","Aurinia","Calcineurin inhibitor","Other indication","Lupus nephritis","lupus nephritis","EFO_0005761","Original","Serious",2021,"P, F",TRUE,2021,FALSE,TRUE,FALSE
"Lutathera","Lutetium Lu 177 dotatate","LUTETIUM LU 177 DOTATATE","CHEMBL3989924","ENSG00000139874, ENSG00000162009, ENSG00000278195, ENSG00000132671, ENSG00000180616","Original","Advanced Accelerator Applications/Novartis","Somatostatin receptor-targeted radiopharmaceutical","Oncology","GEP-NETs","digestive system neuroendocrine neoplasm","MONDO_0024503","Original","Serious",2018,"P, O, F",TRUE,2018,TRUE,FALSE,FALSE
"Luzu","Luliconazole","LULICONAZOLE","CHEMBL2105689",NA,"Original","Medicis","Azole antifungal","No human target","Interdigital tinea pedis, tinea cruris and tinea corporis caused by Trichophyton rubrum and Epidermophyton floccosum","tinea","EFO_0007510","Original","Not serious",2013,"S",NA,NA,NA,NA,NA
"Lybalvi","Olanzapine; samidorphan","samidorphan; Olanzapine","CHEMBL426084; CHEMBL715","ENSG00000112038, ENSG00000116329, ENSG00000082556; ENSG00000102468, ENSG00000147246, ENSG00000151577, ENSG00000069696, ENSG00000149295","Original","Alkermes","Atypical antipsychotic and opioid antagonist","Other indication","Schizophrenia and bipolar I disorder","Schizophrenia; bipolar I disorder","MONDO_0005090; EFO_0009963","Original","Serious",2021,"S",TRUE,2021,FALSE,FALSE,FALSE
"Lymphoseek kit","Technetium TC 99m tilmanocept","TECHNETIUM TC 99M TILMANOCEPT","CHEMBL2108726","ENSG00000260314","Original","Navidea","Radioactive diagnostic agent","Other indication","Lymphatic mapping in patients with breast cancer or melanoma","breast cancer; melanoma","MONDO_0007254; EFO_0000756","Original","Serious",2013,"S",FALSE,2013,FALSE,FALSE,FALSE
"Lynparza","Olaparib","OLAPARIB","CHEMBL521686","ENSG00000143799, ENSG00000041880, ENSG00000129484","Original","AstraZeneca","PARP inhibitor","Oncology","Advanced BRCA-mutated ovarian cancer","ovarian cancer","MONDO_0008170","Original","Serious",2014,"P, O, A, F",TRUE,2014,FALSE,FALSE,FALSE
"Lytgobi","Futibatinib","Futibatinib","CHEMBL3701238","ENSG00000068078, ENSG00000077782, ENSG00000160867, ENSG00000066468","Original","Taiho Oncology","FGFR kinase inhibitor","Oncology","FGFR2-aberrant intrahepatic cholangiocarcinoma","intrahepatic cholangiocarcinoma","EFO_1001961","Original","Serious",2022,"P, O, B, A, F",TRUE,2022,FALSE,TRUE,FALSE
"Macrilen","Macimorelin","MACIMORELIN","CHEMBL278623","ENSG00000121853","Original","Aeterna Zentaris","Growth hormone secretagogue receptor agonist","Other indication","Diagnosis of adult growth hormone deficiency","short stature due to GHSR deficiency","MONDO_0014403","Original","Not serious",2017,"S, O",TRUE,2017,FALSE,FALSE,FALSE
"Margenza","Margetuximab","MARGETUXIMAB","CHEMBL2364649","ENSG00000141736","Original","MacroGenics","HER2-directed mAb","Oncology","HER2-positive breast cancer","HER2 Positive Breast Carcinoma","EFO_1000294","Original","Serious",2020,"S, F",TRUE,2020,FALSE,FALSE,FALSE
"Mavyret","Glecaprevir; pibrentasvir","GLECAPREVIR; PIBRENTASVIR","CHEMBL3545363; CHEMBL3545123","NA; NA","Original","AbbVie","NS3/4A protease inhibitor plus a NS5A inhibitor","No human target","HCV","hepatitis C virus infection","EFO_0003047","Original","Serious",2017,"P, B, F",NA,NA,NA,NA,NA
"Mayzent","Siponimod","SIPONIMOD","CHEMBL2336071","ENSG00000170989","Original","Novartis","S1P receptor modulator","Other indication","Relapsing forms of multiple sclerosis","relapsing-remitting multiple sclerosis","EFO_0003929","Original","Serious",2019,"S",FALSE,2019,FALSE,FALSE,FALSE
"Mekinist","Trametinib","TRAMETINIB","CHEMBL2103875","ENSG00000169032, ENSG00000126934","Original","GSK","MEK1 and MEK2 kinase inhibitor","Oncology","Unresectable or metastatic melanoma with BRAF(V600E) mutation as detected by an FDA-approved test","metastatic melanoma","EFO_0002617","Original","Serious",2013,"S, O, F",TRUE,2013,FALSE,TRUE,FALSE
"Mektovi","Binimetinib","BINIMETINIB","CHEMBL3187723","ENSG00000169032, ENSG00000126934","Original","Array BioPharma","MEK inhibitor","Oncology","BRAF-mutated melanoma","melanoma","EFO_0000756","Original","Serious",2018,"S, O",TRUE,2018,FALSE,FALSE,FALSE
"Mepsevii","Vestronidase alfa","VESTRONIDASE ALFA","CHEMBL3707382","ENSG00000169919","Original","Ultragenyx","Recombinant human lysosomal ‚Äö√¢√†‚àö‚â†‚Äö√Ñ√∂‚àö¬¢¬¨√ü-glucuronidase","Other indication","Mucopolysaccharidosis VII","mucopolysaccharidosis type 7","MONDO_0009662","Original","Serious",2017,"P, O, F",TRUE,2017,FALSE,FALSE,FALSE
"Monjuvi","Tafasitamab","TAFASITAMAB","CHEMBL4298047","ENSG00000177455","Original","MorphoSys","CD19-directed mAb","Oncology","DLBCL","diffuse large b-cell lymphoma","EFO_0000403","Original","Serious",2020,"P, O, B, A, F",TRUE,2020,FALSE,TRUE,FALSE
"Motegrity","Prucalopride","PRUCALOPRIDE","CHEMBL117287","ENSG00000164270","Original","Shire/Takeda","5-HT4-receptor agonist","Other indication","Chronic idiopathic constipation","constipation disorder","MONDO_0002203","Original","Not serious",2018,"S",FALSE,2018,FALSE,FALSE,FALSE
"Mounjaro","Tirzepatide","Tirzepatide","CHEMBL4297839","ENSG00000010310, ENSG00000112164","Original","Eli Lilly","GIP receptor and GLP1 receptor agonist","Other indication","Type 2 diabetes","type 2 diabetes mellitus","MONDO_0005148","Original","Not concordant",2022,"S",TRUE,2022,FALSE,FALSE,FALSE
"Movantik","Naloxegol","NALOXEGOL","CHEMBL2219418","ENSG00000112038","Original","AstraZeneca","Opioid-receptor antagonist","Other indication","Opioid-induced constipation","Constipation","HP_0002019","Original","Not serious",2014,"S",FALSE,2014,FALSE,FALSE,FALSE
"Moxidectin","Moxidectin","MOXIDECTIN","CHEMBL2104415",NA,"Original","Medicines Development for Global Health","Antihelmintic GABA receptor and glutamate channel modulator","No human target","River blindness","ocular onchocerciasis","EFO_0007398","Original","Not concordant",2018,"P, O",NA,NA,NA,NA,NA
"Mulpleta","Lusutrombopag","LUSUTROMBOPAG","CHEMBL2107831","ENSG00000117400","Original","Shionogi","Thrombopoietin receptor agonist","Other indication","Thrombocytopenia","thrombocytopenia","HP_0001873","Original","Not concordant",2018,"P, F",TRUE,2018,FALSE,FALSE,FALSE
"Myalept","Metreleptin","METRELEPTIN","CHEMBL2107857","ENSG00000116678","Original","Amylin","Leptin analogue","Other indication","Leptin deficiency in patients with congenital or acquired generalized lipodystrophy","congenital generalized lipodystrophy","EFO_1000681","Original","Serious",2014,"P, O, F",TRUE,2014,FALSE,FALSE,FALSE
"Natpara","Parathyroid hormone","PARATHYROID HORMONE","CHEMBL2108078","ENSG00000160801","Original","NPS Pharma","Hormonal injection","Other indication","Hypocalcaemia in patients with hypoparathyroidism","hypoparathyroidism; Hypocalcemia","EFO_0009451; HP_0002901","Original","Not concordant",2015,"S, O",TRUE,2015,FALSE,FALSE,FALSE
"Nerlynx","Neratinib","NERATINIB","CHEMBL180022","ENSG00000178568, ENSG00000146648, ENSG00000141736","Original","Puma Biotechnology","EGFR, HER2 and HER4 irreversible kinase inhibitor","Oncology","HER2-overexpressed breast cancer","HER2 Positive Breast Carcinoma","EFO_1000294","Original","Serious",2017,"S",TRUE,2017,FALSE,FALSE,FALSE
"Nesina","Alogliptin","ALOGLIPTIN","CHEMBL376359","ENSG00000197635","Original","Takeda","DPP4 inhibitor","Other indication","Type 2 diabetes","type 2 diabetes mellitus","MONDO_0005148","Original","Not concordant",2013,"S",TRUE,2013,FALSE,FALSE,FALSE
"Netspot","Gallium Ga-68 dotatate","GALLIUM GA-68 DOTATATE","CHEMBL4297340","ENSG00000180616","Original","Advanced Accelerator Applications","Radioactive diagnostic","Other indication","Neuroendocrine tumours","neuroendocrine neoplasm","EFO_1001901","Original","Serious",2016,"P, O",TRUE,2016,TRUE,FALSE,FALSE
"Neuraceq","Florbetaben-F18","FLORBETABEN-F18","CHEMBL566752","ENSG00000142192","Original","Piramal Imaging","Radioactive diagnostic agent","Other indication","Imaging of the brain to estimate density of neuritic amyloid-beta plaques","neuritic plaque measurement; Alzheimer disease","EFO_0006798; MONDO_0004975","Original","Serious",2014,"S",TRUE,2014,FALSE,FALSE,FALSE
"Nexletol","Bempedoic acid","BEMPEDOIC ACID","CHEMBL3545313","ENSG00000131473","Original","Esperion Therapeutics","ACL inhibitor","Other indication","HeFH or atherosclerotic cardiovascular disease","atherosclerosis; familial hypercholesterolemia","EFO_0003914; EFO_0004911","Original","Serious",2020,"S",FALSE,2020,FALSE,FALSE,FALSE
"NexoBrid","Anacaulase","Anacaulase",NA,NA,"Original","Mediwound","Proteolytic enzymes from pineapple plants","No human target","Eschar removal after thermal burns",NA,NA,"Original",NA,2022,"S, O",NA,NA,NA,NA,NA
"Nextstellis","Drospirenone; estetrol","Drospirenone; estetrol","CHEMBL1509; CHEMBL1230314","ENSG00000151623, ENSG00000082175; ENSG00000091831, ENSG00000140009","Original","Mayne Pharma","Spironolactone and oestrogen analogues","Other indication","To prevent pregnancy","reproductive behaviour measurement","EFO_0007862","Original","Not serious",2021,"S",TRUE,2021,FALSE,FALSE,FALSE
"Nexviazyme","Avalglucosidase alfa","Avalglucosidase alfa","CHEMBL4594320","ENSG00000171298","Original","Sanofi","Recombinant alpha-glucosidase","Other indication","Pompe disease","glycogen storage disease II","MONDO_0009290","Original","Serious",2021,"P, O, B, F",TRUE,2021,FALSE,FALSE,FALSE
"Ninlaro","Ixazomib","IXAZOMIB","CHEMBL2141296","ENSG00000165916, ENSG00000240065, ENSG00000159377, ENSG00000108671, ENSG00000100804, ENSG00000161057, ENSG00000154611, ENSG00000159352, ENSG00000100902, ENSG00000013275, ENSG00000173692, ENSG00000101182, ENSG00000103035, ENSG00000129084, ENSG00000142507, ENSG00000222028, ENSG00000197170, ENSG00000175166, ENSG00000205220, ENSG00000100764, ENSG00000277791, ENSG00000136930, ENSG00000099341, ENSG00000163636, ENSG00000185627, ENSG00000127922, ENSG00000115233, ENSG00000087191, ENSG00000108344, ENSG00000204264, ENSG00000100519, ENSG00000100567, ENSG00000143106, ENSG00000126067, ENSG00000130706, ENSG00000106588, ENSG00000008018, ENSG00000041357","Original","Takeda","Oral proteasome inhibitor","Oncology","Multiple myeloma","multiple myeloma","EFO_0001378","Original","Serious",2015,"P, O",TRUE,2015,FALSE,FALSE,FALSE
"Northera","Droxidopa","DROXIDOPA","CHEMBL2103827","ENSG00000169252, ENSG00000170214, ENSG00000043591, ENSG00000120907, ENSG00000274286, ENSG00000184160, ENSG00000188778, ENSG00000150594, ENSG00000171873","Original","Lundbeck","Synthetic amino-acid precursor of noradrenaline; MOA unknown","Other indication","Light-headedness in patients with neurogenic orthostatic hypotension","primary orthostatic hypotension","MONDO_0015914","Original","Not serious",2014,"P, O, A, F",TRUE,2014,TRUE,FALSE,FALSE
"Nourianz","Istradefylline","ISTRADEFYLLINE","CHEMBL431770","ENSG00000128271","Original","Kyowa Kirin","Adenosine receptor antagonist","Other indication","Parkinson disease episodes","Parkinson disease","MONDO_0005180","Original","Serious",2019,"S",TRUE,2019,TRUE,FALSE,FALSE
"Nubeqa","Darolutamide","DAROLUTAMIDE","CHEMBL4297185","ENSG00000169083","Original","Bayer","Androgen receptor inhibitor","Oncology","Prostate cancer","prostate cancer","MONDO_0008315","Original","Serious",2019,"P, F",TRUE,2019,FALSE,FALSE,FALSE
"Nucala","Mepolizumab","MEPOLIZUMAB","CHEMBL2108429","ENSG00000113525","Original","GlaxoSmithKline","IL-5 antagonist","Other indication","Serious asthma","Status Asthmaticus","EFO_0008590","Original","Serious",2015,"S, F",TRUE,2015,FALSE,TRUE,FALSE
"Nulibry","Fosdenopterin","Fosdenopterin","CHEMBL2338675","ENSG00000164172","Original","BridgeBio","cPMP","Other indication","MoCD type A","sulfite oxidase deficiency due to molybdenum cofactor deficiency","MONDO_0020480","Original","Serious",2021,"P, O, B",TRUE,2021,FALSE,FALSE,FALSE
"Nuplazid","Pimavanserin","PIMAVANSERIN","CHEMBL2111101","ENSG00000102468","Original","Acadia Pharmaceuticals","Atypical antipsychotic","Other indication","Hallucinations and delusions associated with Parkinson disease psychosis","Parkinson disease; psychosis","MONDO_0005180; EFO_0005407","Original","Serious",2016,"P, B",TRUE,2016,FALSE,FALSE,FALSE
"Nurtec ODT","Rimegepant","RIMEGEPANT","CHEMBL2178422","ENSG00000064989","Original","Biohaven","CGRP receptor antagonist","Other indication","Migraine","migraine disorder","MONDO_0005277","Original","Not serious",2020,"S",TRUE,2020,TRUE,FALSE,FALSE
"Nuzyra","Omadacycline","OMADACYCLINE","CHEMBL1689772",NA,"Original","Paratek Pharmaceuticals","Tetracycline antibiotic","No human target","CABP and ABSSSI","bacterial pneumonia; skin disease caused by bacterial infection","EFO_1001272; MONDO_0024295","Original","Serious",2018,"P, F",NA,NA,NA,NA,NA
"Ocaliva","Obeticholic acid","OBETICHOLIC ACID","CHEMBL566315","ENSG00000012504","Original","Intercept","FXR agonist","Other indication","Primary biliary cholangitis","primary biliary cirrhosis","EFO_1001486","Original","Serious",2016,"P, O, A, F",TRUE,2016,FALSE,TRUE,FALSE
"Ocrevus","Ocrelizumab","OCRELIZUMAB","CHEMBL2108041","ENSG00000156738","Original","Roche/Genentech","CD20-directed cytolytic antibody","Other indication","Relapsing or primary progressive forms of multiple sclerosis","chronic progressive multiple sclerosis","EFO_0003840","Original","Serious",2017,"P, B, F",FALSE,2017,FALSE,FALSE,FALSE
"Odomzo","Sonidegib","SONIDEGIB","CHEMBL2105737","ENSG00000128602","Original","Novartis","Smoothened inhibitor","Oncology","Basal cell carcinoma","basal cell carcinoma","EFO_0004193","Original","Not serious",2015,"S",TRUE,2015,FALSE,FALSE,FALSE
"Ofev","Nintedanib","NINTEDANIB","CHEMBL502835","ENSG00000102755, ENSG00000037280, ENSG00000128052, ENSG00000066468, ENSG00000077782, ENSG00000160867, ENSG00000134853, ENSG00000113721, ENSG00000068078","Original","Boehringer Ingelheim","Kinase inhibitor against PDGFRs, FGFRs, VEGFRs and FLT3","Other indication","IPF (idiopathic pulmonary fibrosis)","idiopathic pulmonary fibrosis","EFO_0000768","Original","Serious",2014,"P, O, B, F",TRUE,2014,TRUE,FALSE,FALSE
"Olinvyk","Oliceridine","OLICERIDINE","CHEMBL2443262","ENSG00000112038","Original","Trevena","Opioid receptor agonist","Other indication","Acute pain","pain","EFO_0003843","Original","Not serious",2020,"S, F",FALSE,2020,FALSE,FALSE,FALSE
"Olumiant","Baricitinib","BARICITINIB","CHEMBL2105759","ENSG00000096968, ENSG00000162434","Original","Incyte/Eli Lilly","JAK inhibitor","Other indication","Rheumatoid arthritis","rheumatoid arthritis","EFO_0000685","Original","Serious",2018,"S",TRUE,2018,FALSE,FALSE,FALSE
"Olysio","Simeprevir","SIMEPREVIR","CHEMBL501849",NA,"Original","Janssen","HCV NS3/4A protease inhibitor","No human target","Chronic HCV infection, as a component of a combination antiviral treatment regimen","hepatitis C virus infection","EFO_0003047","Original","Serious",2013,"P, F",NA,NA,NA,NA,NA
"Omegaven","Fish oil triglycerides","FISH OIL TRIGLYCERIDES","CHEMBL4297535",NA,"Original","Fresenius","Mixture of fatty acids","No human target","Parenteral nutrition-associated cholestasis","cholestasis","MONDO_0001751","Original","Serious",2018,"P, O, F",NA,NA,NA,NA,NA
"Omlonti","Omidenepag isopropyl","Omidenepag isopropyl","CHEMBL4297666","ENSG00000125384","Original","Santen","Prostaglandin E2 receptor agonist","Other indication","Intraocular pressure in open-angle glaucoma or ocular hypertension","ocular hypertension, open-angle glaucoma","EFO_1001069; EFO_0004190","Original","Serious",2022,"S",FALSE,2022,FALSE,FALSE,FALSE
"Ongentys","Opicapone","OPICAPONE","CHEMBL1089318","ENSG00000093010","Original","Neurocrine","COMT inhibitor","Other indication","Parkinson disease","parkinson disease","MONDO_0005180","Original","Serious",2020,"S",TRUE,2020,FALSE,FALSE,FALSE
"Onpattro","Patisiran","PATISIRAN","CHEMBL3989987","ENSG00000118271","Original","Alnylam Pharmaceuticals","TTR-directed small interfering RNA","Other indication","Hereditary TTR-mediated amyloidosis","hereditary ATTR amyloidosis","MONDO_0017132","Original","Serious",2018,"P, O, B, F",TRUE,2018,FALSE,FALSE,FALSE
"Opdivo","Nivolumab","NIVOLUMAB","CHEMBL2108738","ENSG00000188389","Original","Bristol-Myers Squibb","PD1 inhibitor","Oncology","Unresectable or metastatic melanoma","metastatic melanoma","EFO_0002617","Original","Serious",2014,"P, O, B, A, F",FALSE,2014,FALSE,FALSE,FALSE
"Opdualag","Relatlimab; nivolumab","Relatlimab; nivolumab","CHEMBL3990044; CHEMBL2108738","ENSG00000089692; ENSG00000188389","Original","Bristol Myers Squibb","LAG3-targeted mAb plus PD1-targeted mAb","Oncology","Melanoma","melanoma","EFO_0000756","Original","Serious",2022,"P, O, F",TRUE,2022,TRUE,TRUE,FALSE
"Opsumit","Macitentan","MACITENTAN","CHEMBL2103873","ENSG00000136160, ENSG00000151617","Original","Actelion","Endothelin receptor antagonist","Other indication","Pulmonary arterial hypertension","pulmonary arterial hypertension","EFO_0001361","Original","Serious",2013,"S, O",TRUE,2013,FALSE,TRUE,FALSE
"Orbactiv","Oritavancin","ORITAVANCIN","CHEMBL1688530",NA,"Original","The Medicines Company","Semi-synthetic lipoglycopeptide","No human target","ABSSSI (Acute Bacterial Skin and Skin Structure Infections)","staphylococcal skin infections","EFO_1001849","Original","Not serious",2014,"P",NA,NA,NA,NA,NA
"Orgovyx","Relugolix","RELUGOLIX","CHEMBL1800159","ENSG00000109163","Original","Myovant Sciences","GnRH receptor antagonist","Oncology","Prostate cancer","prostate cancer","MONDO_0008315","Original","Serious",2020,"P",TRUE,2020,FALSE,FALSE,FALSE
"Orilissa","Elagolix sodium","ELAGOLIX SODIUM","CHEMBL502182","ENSG00000109163","Original","AbbVie","GnRH receptor antagonist","Other indication","Pain associated with endometriosis","adenomyosis; pain","MONDO_0010888; EFO_0003843","Original","Not serious",2018,"P",TRUE,2018,FALSE,FALSE,FALSE
"Orkambi","Ivacaftor; lumacaftor","IVACAFTOR; LUMACAFTOR","CHEMBL2010601; CHEMBL2103870","ENSG00000001626; ENSG00000001626","Original","Vertex","CFTR potentiator plus CFTR corrector","Other indication","Cystic fibrosis in patients with homozygous DF508 CFTR mutation","cystic fibrosis","MONDO_0009061","Original","Serious",2015,"P, O, B, F",TRUE,2015,FALSE,FALSE,FALSE
"Orladeyo","Berotralstatc","BEROTRALSTAT","CHEMBL4594271","ENSG00000164344","Original","BioCryst","Plasma kallikrein inhibitor","#N/A","Hereditary angioedema","hereditary angioedema","MONDO_0019623","Original","Serious",2020,"S, O, F",FALSE,NA,NA,NA,NA
"Osphena","Ospemifene","OSPEMIFENE","CHEMBL2105395","ENSG00000140009, ENSG00000091831","Original","Shionogi","Oestrogen receptor modulator","Other indication","Moderate to Serious dyspareunia due to menopause","Dyspareunia; menopause","HP_0030016; EFO_0003922","Original","Not serious",2013,"S",TRUE,2013,TRUE,FALSE,FALSE
"Otezla","Apremilast","APREMILAST","CHEMBL514800","ENSG00000184588, ENSG00000065989, ENSG00000105650, ENSG00000113448","Original","Celgene","Phosphodiesterase 4 inhibitor","Other indication","Psoriatic arthritis and plaque psoriasis","psoriatic arthritis; psoriasis vulgaris","EFO_0003778; EFO_1001494","Original","Serious",2014,"S",TRUE,2014,FALSE,TRUE,FALSE
"Oxbryta","Voxelotor","VOXELOTOR","CHEMBL4101807","ENSG00000206172, ENSG00000244734, ENSG00000188536","Original","Global Blood Therapeutics","Haemoglobin S polymerization inhibitor","Other indication","SCD (sickle cell disease)","sickle cell anemia","MONDO_0011382","Original","Serious",2019,"P, O, B, A, F",TRUE,2019,FALSE,FALSE,FALSE
"Oxervate","Cenegermin","CENEGERMIN","CHEMBL4297852","ENSG00000140538, ENSG00000148053, ENSG00000198400","Original","Domp‚Äö√Ñ√∂‚àö‚Ä†‚àö‚àÇ¬¨¬®¬¨¬©","Recombinant NGF","Other indication","Neurotrophic keratitis","keratitis","EFO_0009449","Original","Not serious",2018,"P, O, B, F",TRUE,2018,TRUE,FALSE,FALSE
"Oxlumo","Lumasiran","LUMASIRAN","CHEMBL4297779","ENSG00000101323","Original","Alnylam","HAO1-directed siRNA","Other indication","Hyperoxaluria type 1","primary hyperoxaluria type 1","MONDO_0009823","Original","Serious",2020,"P, O, B",FALSE,2020,FALSE,FALSE,FALSE
"Ozempic","Semaglutide","SEMAGLUTIDE","CHEMBL2108724","ENSG00000112164","Original","Novo Nordisk","GLP1 receptor agonist","Other indication","Type 2 diabetes mellitus","type 2 diabetes mellitus","MONDO_0005148","Original","Not concordant",2017,"S",TRUE,2017,FALSE,FALSE,FALSE
"PSMA-11 Ga-68","PSMA-11 Ga-68","PSMA-11 GA-68","CHEMBL4297335","ENSG00000142515","Original","UCLA","Radioactive diagnostic","Other indication","Imaging, prostate cancer","prostate carcinoma","EFO_0001663","Original","Serious",2020,"S",TRUE,2020,FALSE,FALSE,FALSE
"Padcev","Enfortumab vedotin","ENFORTUMAB VEDOTIN","CHEMBL3301589","ENSG00000143217, ENSG00000101162, ENSG00000167552, ENSG00000261456, ENSG00000127824, ENSG00000123416, ENSG00000258947, ENSG00000198033, ENSG00000188229, ENSG00000152086, ENSG00000137267, ENSG00000104833, ENSG00000167553, ENSG00000137285, ENSG00000196230, ENSG00000176014","Original","Astellas","Nectin-4-directed ADC","Oncology","Urothelial cancers","urothelial neoplasm","MONDO_0024337","Original","Serious",2019,"P, B, A",TRUE,2019,TRUE,FALSE,FALSE
"Palynziq","Pegvaliase","PEGVALIASE","CHEMBL4297802",NA,"Original","BioMarin Pharmaceutical","PAL replacement therapy","No human target","Phenylketonuria","phenylketonuria","MONDO_0009861","Original","Serious",2018,"P, O, F",NA,NA,NA,NA,NA
"Parsabiv","Etelcalcetide","VELCALCETIDE","CHEMBL3545184","ENSG00000036828","Original","Amgen/Kai Pharmaceuticals","Calcium-sensing receptor agonist","Other indication","Secondary hyperparathyroidism in patients with chronic kidney disease on haemodialysis","hyperparathyroidism","EFO_0008506","Original","Not serious",2017,"S",TRUE,2017,FALSE,FALSE,FALSE
"Pemazyre","Pemigatinib","PEMIGATINIB","CHEMBL4297522","ENSG00000066468, ENSG00000068078, ENSG00000077782","Original","Incyte","FGFR1-3 kinase inhibitor","Oncology","Cholangiocarcinoma","cholangiocarcinoma","EFO_0005221","Original","Serious",2020,"P, O, B, A",TRUE,2020,FALSE,FALSE,FALSE
"Pepaxto","Melphalan flufenamide","Melphalan flufenamide","CHEMBL4303060",NA,"Original","Oncopeptides","Peptide-conjugated alkylating drug",NA,"Multiple myeloma","multiple myeloma","EFO_0001378","Original","Serious",2021,"P, O, A",NA,NA,NA,NA,NA
"Pifeltro","Doravirine","DORAVIRINE","CHEMBL2364608",NA,"Original","Merck & Co.","NNRTI","No human target","HIV","hiv infection","EFO_0000764","Original","Serious",2018,"S",NA,NA,NA,NA,NA
"Piqray","Alpelisib","ALPELISIB","CHEMBL2396661","ENSG00000121879","Original","Novartis","PI3K inhibitor","Oncology","Breast cancer","breast cancer","MONDO_0007254","Original","Serious",2019,"P",TRUE,2019,FALSE,FALSE,FALSE
"Pizensy","Lactitol","LACTITOL","CHEMBL1661",NA,"Original","Braintree Labs","Osmotic laxative","No human target","Chronic idiopathic constipation","Chronic constipation","HP_0012450","Original","Not serious",2020,"S",NA,NA,NA,NA,NA
"Plegridy","Peginterferon beta-1A","PEGINTERFERON BETA-1A","CHEMBL2108677","ENSG00000159110, ENSG00000142166","Original","Biogen Idec","Long-acting interferon-beta1A","Other indication","Relapsing multiple sclerosis","relapsing-remitting multiple sclerosis","EFO_0003929","Original","Serious",2014,"S",FALSE,2014,FALSE,FALSE,FALSE
"Pluvicto","Lutetium Lu-177 vipivotide tetraxetan","Lutetium Lu-177 vipivotide tetraxetan","CHEMBL4594406","ENSG00000142515","Original","Novartis","PSMA-binding radioligand therapeutic agent","Oncology","PSMA-positive prostate cancer","prostate carcinoma","EFO_0001663","Original","Serious",2022,"P, B",TRUE,2022,FALSE,FALSE,FALSE
"Polivy","Polatuzumab vedotin","POLATUZUMAB VEDOTIN","CHEMBL3301582","ENSG00000198033, ENSG00000167552, ENSG00000261456, ENSG00000176014, ENSG00000258947, ENSG00000123416, ENSG00000101162, ENSG00000188229, ENSG00000152086, ENSG00000007312, ENSG00000137285, ENSG00000167553, ENSG00000196230, ENSG00000137267, ENSG00000127824, ENSG00000104833","Original","Roche","CD79b-directed ADC","Oncology","Diffuse large B-cell lymphoma","diffuse large b-cell lymphoma","EFO_0000403","Original","Serious",2019,"P, O, B, A",TRUE,2019,FALSE,FALSE,FALSE
"Pomalyst","Pomalidomide","POMALIDOMIDE","CHEMBL43452","ENSG00000167986, ENSG00000139842, ENSG00000113851, ENSG00000100387","Original","Celgene","Immunomodulatory antineoplastic agent","Oncology","Multiple myeloma","multiple myeloma","EFO_0001378","Original","Serious",2013,"S, O, F",TRUE,2013,FALSE,FALSE,FALSE
"Ponvory","Ponesimod","Ponesimod","CHEMBL1096146","ENSG00000170989","Original","J&J","S1P receptor modulator","Other indication","Relapsing multiple sclerosis","multiple sclerosis","MONDO_0005301","Original","Serious",2021,"S",TRUE,2021,TRUE,FALSE,FALSE
"Portrazza","Necitumumab","NECITUMUMAB","CHEMBL1743047","ENSG00000146648","Original","Eli Lilly","EGFR antagonist","Oncology","NSCLC","non-small cell lung carcinoma","EFO_0003060","Original","Serious",2015,"S, O, F",TRUE,2015,FALSE,FALSE,FALSE
"Poteligeo","Mogamulizumab","MOGAMULIZUMAB","CHEMBL1743041","ENSG00000183813","Original","Kyowa Hakko Kirin","CCR4 antibody","Oncology","mycosis fungoides or Sezary syndrome","mycosis fungoides","EFO_1001051","Original","Serious",2018,"P, O, B",TRUE,2018,FALSE,TRUE,FALSE
"Praluent","Alirocumab","ALIROCUMAB","CHEMBL2109540","ENSG00000169174","Original","Sanofi","PCSK9 inhibitor","Other indication","LDL lowering","LDL cholesterol change measurement","EFO_0007804","Original","Not serious",2015,"P",TRUE,2015,TRUE,FALSE,FALSE
"Praxbind","Idarucizumab","IDARUCIZUMAB","CHEMBL3544996",NA,"Original","Boehringer Ingelheim","Dabigatran-binding mAb fragment","No human target","Reversal of anticoagulant effects of dabigatran","response to anticoagulant","GO_0061476","Original","Not serious",2015,"P, O, B, A",NA,NA,NA,NA,NA
"Pretomanid","Pretomanid","PRETOMANID","CHEMBL227875",NA,"Original","Pfizer/Mylan","Antimycobacterial","No human target","Tuberculosis","tuberculosis","MONDO_0018076","Original","Serious",2019,"P, O, F",NA,NA,NA,NA,NA
"Prevymis","Letermovir","LETERMOVIR","CHEMBL1241951",NA,"Original","Merck & Co.","CMV DNA terminase complex inhibitor","No human target","Prophylaxis of CMV (cytomegalovirus)","cytomegalovirus infection","EFO_0001062","Original","Serious",2017,"P, O, B, F",NA,NA,NA,NA,NA
"Pylarify","Piflufolastat F-18","Piflufolastat F-18","CHEMBL4297334","ENSG00000086205","Original","Progenics","Radiolabelled PSMA imaging agent","Other indication","Prostate cancer imaging","prostate carcinoma","EFO_0001663","Original","Serious",2021,"P",FALSE,2021,FALSE,FALSE,FALSE
"Pyrukynd","Mitapivat","Mitapivat","CHEMBL4299940","ENSG00000143627","Original","Agios","Pyruvate kinase activator","Other indication","Haemolytic anaemia due to PK deficiency","hemolytic anemia","EFO_0005558","Original","Serious",2022,"P, O, F",TRUE,2022,FALSE,FALSE,FALSE
"Qelbree","Viloxazine","Viloxazine","CHEMBL306700","ENSG00000103546","Original","Supernus","SNRI","Other indication","ADHD","attention deficit hyperactivity disorder","EFO_0003888","Original","Not serious",2021,"S",FALSE,2021,FALSE,FALSE,FALSE
"Qinlock","Ripretinib","RIPRETINIB","CHEMBL4216467","ENSG00000157404, ENSG00000134853","Original","Deciphera","KIT and PDGFRA kinase inhibitor","Oncology","GIST","gastrointestinal stromal tumor","MONDO_0011719","Original","Serious",2020,"P, O, B, F",TRUE,2020,FALSE,FALSE,FALSE
"Qulipta","Atogepant","Atogepant","CHEMBL3991065","ENSG00000064989","Original","AbbVie","CGRP receptor antagonist","Other indication","Episodic migraine","migraine disorder","MONDO_0005277","Original","Not serious",2021,"S",TRUE,2021,TRUE,FALSE,FALSE
"Quviviq","Daridorexant","Daridorexant","CHEMBL4297590","ENSG00000137252, ENSG00000121764","Original","Idorsia","Orexin receptor antagonist","Other indication","Insomnia","insomnia","EFO_0004698","Original","Not serious",2022,"S",TRUE,2022,FALSE,TRUE,FALSE
"Radicava","Edaravone","EDARAVONE","CHEMBL290916",NA,"Original","Mitsubishi Tanabe","Unknown (radical scavenger)","No human target","ALS (amyotrophic lateral sclerosis)","amyotrophic lateral sclerosis","MONDO_0004976","Original","Serious",2017,"S, O",NA,NA,NA,NA,NA
"Rapivab","Peramivir","PERAMIVIR; PERAMIVIR","CHEMBL3989402; CHEMBL139367","NA; NA","Original","BioCryst","Neuraminidase inhibitor","No human target","Influenza infection","influenza","EFO_0007328","Original","Not serious",2014,"S, F",NA,NA,NA,NA,NA
"Reblozyl","Luspatercept","LUSPATERCEPT","CHEMBL3039545","ENSG00000105329, ENSG00000092969, ENSG00000119699","Original","Celgene/BMS","Erythroid maturation agent","Other indication","Anaemia in beta-thalassaemia","beta thalassemia; anemia","MONDO_0019402; MONDO_0002280","Original","Serious",2019,"P, O, F",TRUE,2019,FALSE,FALSE,FALSE
"Recarbrio","Cilastatin; imipenem; relebactam","CILASTATIN; IMIPENEM; RELEBACTAM","CHEMBL766; CHEMBL148; CHEMBL3301605","ENSG00000015413; NA; NA","Original","Merck & Co.","A renal dehydropeptidase inhibitor, a penem antibacterial and a beta-lactamase inhibitor","No human target","Complicated urinary tract and complicated intra-abdominal infections","urinary tract infection","EFO_0003103","Original","Not serious",2019,"P, F",NA,2019,FALSE,FALSE,FALSE
"Relyvrio","Sodium phenylbutyrate; taurursodiol","Sodium phenylbutyrate; taurursodiol","CHEMBL1746; CHEMBL272427","NA; NA","Original","Amylyx","Mechanism unknown","No human target","Amyotrophic lateral sclerosis","amyotrophic lateral sclerosis","MONDO_0004976","Original","Serious",2022,"P, O",NA,NA,NA,NA,NA
"Repatha","Evolocumab","EVOLOCUMAB","CHEMBL2364655","ENSG00000169174","Original","Amgen","PCSK9 inhibitor","Other indication","LDL lowering","LDL cholesterol change measurement","EFO_0007804","Original","Not serious",2015,"S, O",TRUE,2015,TRUE,FALSE,FALSE
"Retevmo","Selpercatinib","SELPERCATINIB","CHEMBL4559134","ENSG00000108091, ENSG00000165731, ENSG00000170759","Original","Eli Lilly/Loxo Oncology","RET kinase inhibitor","Oncology","RET fusion-positive NSCLC and thyroid cancer","non-small cell lung carcinoma; thyroid cancer","EFO_0003060; MONDO_0002108","Original","Serious",2020,"P, O, B, A",TRUE,2020,FALSE,FALSE,FALSE
"Revcovi","Elapegademase","ELAPEGADEMASE","CHEMBL3990026","ENSG00000196839","Original","Leadiant Biosciences","Recombinant adenosine deaminase","Other indication","ADA-SCID","Serious combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-negative, due to adenosine deaminase deficiency","MONDO_0007064","Original","Serious",2018,"P, O, F",TRUE,2018,FALSE,FALSE,FALSE
"Rexulti","Brexpiprazole","BREXPIPRAZOLE","CHEMBL2105760","ENSG00000149295, ENSG00000178394, ENSG00000102468","Original","Otsuka","Atypical antipsychotic","Other indication","MDD and schizophrenia","major depressive disorder; schizophrenia","MONDO_0002009; MONDO_0005090","Original","Serious",2015,"S",TRUE,2015,FALSE,FALSE,FALSE
"Reyvow","Lasmiditan","LASMIDITAN","CHEMBL3039520","ENSG00000179097","Original","Eli Lilly","Serotonin (5-HT) 1F receptor agonist","Other indication","Migraine with or without aura","migraine disorder","MONDO_0005277","Original","Not serious",2019,"S",FALSE,2019,FALSE,FALSE,FALSE
"Rezlidhia","Olutasidenib","Olutasidenib","CHEMBL4297610","ENSG00000138413","Original","Rigel/Forma","IDH1 inhibitor","Oncology","IDH1-mutated AML","acute myeloid leukemia","EFO_0000222","Original","Serious",2022,"S, O",TRUE,2022,FALSE,FALSE,FALSE
"Rezurock","Belumosudil","Belumosudil","CHEMBL2005186","ENSG00000134318, ENSG00000067900","Original","Kadmon","ROCK2 kinase inhibitor","Other indication","Chronic GVHD","graft versus host disease","MONDO_0013730","Original","Serious",2021,"P, O, B",FALSE,2021,FALSE,FALSE,FALSE
"Rhopressa","Netarsudil","NETARSUDIL","CHEMBL4594250","ENSG00000134318, ENSG00000067900","Original","Aerie Pharmaceuticals","RHO kinase inhibitor","Other indication","Open-angle glaucoma or ocular hypertension","open-angle glaucoma; ocular hypertension","EFO_0004190; EFO_1001069","Original","Serious",2017,"P",FALSE,2017,FALSE,FALSE,FALSE
"Rinvoq","Upadacitinib","UPADACITINIB","CHEMBL3622821","ENSG00000162434, ENSG00000096968, ENSG00000105397, ENSG00000105639","Original","AbbVie","JAK inhibitor","Other indication","Rheumatoid arthritis","rheumatoid arthritis","EFO_0000685","Original","Serious",2019,"S",TRUE,2019,FALSE,FALSE,FALSE
"Rolvedon","Eflapegrastim","Eflapegrastim","CHEMBL3833384","ENSG00000119535","Original","Spectrum","Leukocyte growth factor","Other indication","Incidence of infection in non-myeloid malignancies, with myelosuppressive drugs","infection","EFO_0000544","Original","Serious",2022,"S",TRUE,2022,FALSE,TRUE,FALSE
"Rozlytrek","Entrectinib","ENTRECTINIB","CHEMBL1983268","ENSG00000148053, ENSG00000198400, ENSG00000140538, ENSG00000047936, ENSG00000171094","Original","Roche","TRKA, TRKB, TRKC, ROS1 and ALK inhibitor","Oncology","NTRK fusion-positive solid tumours and ROS1-positive NSCLC","non-small cell lung carcinoma","EFO_0003060","Original","Serious",2019,"P, O, B, A",TRUE,2019,FALSE,FALSE,FALSE
"Rubraca","Rucaparib","RUCAPARIB","CHEMBL1173055","ENSG00000041880, ENSG00000129484, ENSG00000143799","Original","Clovis Oncology","PARP inhibitor","Oncology","BRCA-positive ovarian cancer","ovarian cancer","MONDO_0008170","Original","Serious",2016,"P, O, B, A",TRUE,2016,FALSE,FALSE,FALSE
"Rukobia","Fostemsavir","FOSTEMSAVIR","CHEMBL3301594",NA,"Original","ViiV Healthcare","Attachment inhibitor","No human target","HIV","hiv infection","EFO_0000764","Original","Serious",2020,"P, B, F",NA,NA,NA,NA,NA
"Rybrevant","Amivantamab","Amivantamab","CHEMBL4297774","ENSG00000105976, ENSG00000146648","Original","J&J","EGFRxMETR bispecific antibody","Oncology","EGFR exon 20-mutated NSCLC","non-small cell lung carcinoma","EFO_0003060","Original","Serious",2021,"P, B, A",TRUE,2021,FALSE,FALSE,FALSE
"Rydapt","Midostaurin","MIDOSTAURIN","CHEMBL608533","ENSG00000163932, ENSG00000115825, ENSG00000166501, ENSG00000171132, ENSG00000163558, ENSG00000184304, ENSG00000065675, ENSG00000126583, ENSG00000027075, ENSG00000067606, ENSG00000154229, ENSG00000128052, ENSG00000122025, ENSG00000157404, ENSG00000134853, ENSG00000113721","Original","Novartis","FLT3 inhibitor","Oncology","FLT3-positive AML","acute myeloid leukemia, FLT3 internal tandem duplication","MONDO_0100415","Original","Serious",2017,"P, O, B, F",TRUE,2017,FALSE,TRUE,FALSE
"Rylaze","Asparaginase erwinia chrysanthemi","Asparaginase erwinia chrysanthemi","CHEMBL1863514",NA,"Original","Jazz","Recombinant asparagine-specific enzyme",NA,"ALL and LBL, in patients allergic to E. coli-derived products","acute lymphoblastic leukemia; lymphoblastic lymphoma","EFO_0000220; MONDO_0000873","Original","Serious",2021,"S, O, F",NA,NA,NA,NA,NA
"Saphnelo","Anifrolumab","Anifrolumab","CHEMBL2364653","ENSG00000142166","Original","AstraZeneca","IFNAR-targeted mAb","Other indication","SLE","systemic lupus erythematosus","MONDO_0007915","Original","Serious",2021,"S, F",TRUE,2021,TRUE,FALSE,FALSE
"Sarclisa","Isatuximab","ISATUXIMAB","CHEMBL3545131","ENSG00000004468","Original","Sanofi","CD38-directed mAb","Oncology","Multiple myeloma","multiple myeloma","EFO_0001378","Original","Serious",2020,"S, O",TRUE,2020,FALSE,TRUE,FALSE
"Savaysa","Edoxaban","EDOXABAN","CHEMBL1269025","ENSG00000126218","Original","Daiichi Sankyo","Factor Xa inhibitor","Other indication","Risk of stroke and systemic embolism in NVAF, and deep vein thrombosis","atrial fibrillation; deep vein thrombosis","EFO_0000275; EFO_0003907","Original","Serious",2015,"S",TRUE,2015,FALSE,FALSE,FALSE
"Scemblix","Asciminib","Asciminib","CHEMBL4208229","ENSG00000097007","Original","Novartis","ABL/BCR-ABL1  kinase inhibitor","Oncology","Ph+ CML","Blast Phase Chronic Myelogenous Leukemia; BCR-ABL1 Positive","EFO_1000131","Original","Serious",2021,"P, O, B, A, F",TRUE,2021,FALSE,FALSE,FALSE
"Scenesse","Afamelanotide","AFAMELANOTIDE","CHEMBL441738","ENSG00000258839","Original","Clinuvel","Melanocortin 1 receptor agonist","Other indication","Erythropoietic protoporphyria","erythropoietic protoporphyria","MONDO_0001676","Original","Serious",2019,"P, O, F",TRUE,2019,FALSE,TRUE,FALSE
"Seysara","Sarecycline","SARECYCLINE","CHEMBL2364632",NA,"Original","Allergan","Tetracycline antibiotic","No human target","Serious acne vulgaris","acne","EFO_0003894","Original","Not serious",2018,"S",NA,NA,NA,NA,NA
"Siliq","Brodalumab","BRODALUMAB","CHEMBL1742996","ENSG00000177663","Original","Valeant Pharmaceuticals","IL-17RA antagonist","Other indication","Plaque psoriasis","psoriasis vulgaris","EFO_1001494","Original","Not serious",2017,"S",TRUE,2017,FALSE,TRUE,FALSE
"Sivextro","Tedizolid","TEDIZOLID","CHEMBL1257051",NA,"Original","Cubist","Oxazolidinone-class antibacterial","No human target","ABSSSI (Acute Bacterial Skin and Skin Structure Infections)","staphylococcal skin infections","EFO_1001849","Original","Not serious",2014,"P",NA,NA,NA,NA,NA
"Skyrizi","Risankizumab","RISANKIZUMAB","CHEMBL3990029","ENSG00000110944, ENSG00000113302","Original","AbbVie","IL-23 antagonist","Other indication","Plaque psoriasis","psoriasis vulgaris","EFO_1001494","Original","Not serious",2019,"S",TRUE,2019,FALSE,FALSE,FALSE
"Skytrofa","Lonapegsomatropin","Lonapegsomatropin","CHEMBL4298185","ENSG00000112964","Original","Ascendis Pharma","PEGylated human growth hormone","Other indication","Growth failure due to GHD","Growth delay","HP_0001510","Original","Not serious",2021,"S, O",TRUE,2021,FALSE,FALSE,FALSE
"Sogroya","Somapacitan","SOMAPACITAN","CHEMBL3707290","ENSG00000112964","Original","Novo Nordisk","Growth hormone analogue","Other indication","Growth hormone deficiency","short stature due to partial GHR deficiency","MONDO_0011420","Original","Not serious",2020,"S",TRUE,2020,FALSE,FALSE,FALSE
"Solosec","Secnidazole","SECNIDAZOLE","CHEMBL498847",NA,"Original","Lupin","Nitroimidazole antimicrobial","No human target","Bacterial vaginosis","bacterial vaginosis","EFO_0003932","Original","Not serious",2017,"P, F",NA,NA,NA,NA,NA
"Sotyktu","Deucravacitinib","Deucravacitinib","CHEMBL4435170","ENSG00000105397","Original","Bristol Myers Squibb","TYK2 inhibitor","Other indication","Plaque psoriasis","psoriasis vulgaris","EFO_1001494","Original","Not serious",2022,"S",TRUE,2022,FALSE,FALSE,FALSE
"Sovaldi","Sofosbuvir","SOFOSBUVIR","CHEMBL1259059",NA,"Original","Gilead","HCV nucleotide analogue NS5B polymerase inhibitor","No human target","Chronic HCV infection, as a component of a combination antiviral treatment regimen","hepatitis C virus infection","EFO_0003047","Original","Serious",2013,"P, B, F",NA,NA,NA,NA,NA
"Spevigo","Spesolimab","Spesolimab","CHEMBL4297911","ENSG00000115598, ENSG00000196083","Original","Boehringer Ingelheim","IL-36R-targeted mAb","Other indication","Generalized pustular psoriasis flares","psoriasis 14, pustular","MONDO_0013626","Original","Not concordant",2022,"P, O, B",FALSE,2022,FALSE,FALSE,FALSE
"Spinraza","Nusinersen","NUSINERSEN","CHEMBL3301572","ENSG00000205571","Original","Biogen/Ionis Pharmaceuticals","ASO designed to target SMN2 pre-mRNA","Other indication","Spinal muscular atrophy","spinal muscular atrophy","EFO_0008525","Original","Serious",2016,"P, O, F",TRUE,2016,FALSE,FALSE,FALSE
"Steglatro","Ertugliflozin","ERTUGLIFLOZIN","CHEMBL1770248","ENSG00000140675","Original","Merck & Co./Pfizer","SGLT2 inhibitor","Other indication","Type 2 diabetes mellitus","type 2 diabetes mellitus","MONDO_0005148","Original","Not concordant",2017,"S",TRUE,2017,FALSE,TRUE,FALSE
"Strensiq","Asfotase alfa","ASFOTASE ALFA","CHEMBL2108311","ENSG00000162551","Original","Alexion","Alkaline phosphatase","Other indication","Hypophosphatasia","hypophosphatasia","MONDO_0018570","Original","Serious",2015,"P, O, B, F",TRUE,2015,FALSE,FALSE,FALSE
"Striverdi Respimat","Olodaterol","OLODATEROL","CHEMBL605846","ENSG00000169252","Original","Boehringer Ingelheim","Long-acting beta2-adrenoceptor agonist","Other indication","COPD","chronic obstructive pulmonary disease","EFO_0000341","Original","Serious",2014,"S",TRUE,2014,TRUE,FALSE,FALSE
"Sunlenca","Lenacapavir","Lenacapavir","CHEMBL4594438",NA,"Original","Gilead","HIV-1 capsid inhibitor","No human target","HIV-1 infection","HIV-1 infection","EFO_0000180","Original",NA,2022,"P, B, F",NA,NA,NA,NA,NA
"Sunosi","Solriamfetol","SOLRIAMFETOL","CHEMBL4297620",NA,"Original","Jazz","Dopamine and noradrenaline reuptake inhibitor","No human target","Excessive sleepiness due to narcolepsy or obstructive sleep apnoea","hypersomnia; narcolepsy; obstructive sleep apnea","EFO_0005246; MONDO_0021107; EFO_0003918","Original","Serious",2019,"S, O",NA,NA,NA,NA,NA
"Sylvant","Siltuximab","SILTUXIMAB","CHEMBL1743070","ENSG00000136244","Original","Janssen Biotech","IL-6-specific antibody","Other indication","Multicentric Castleman's disease","Castleman disease","MONDO_0015564","Original","Serious",2014,"P, O",TRUE,2014,FALSE,FALSE,FALSE
"Symdeko","Tezacaftor; ivacaftor","TEZACAFTOR; IVACAFTOR","CHEMBL3544914; CHEMBL2010601","ENSG00000001626; ENSG00000001626","Original","Vertex Pharmaceuticals","CFTR corrector and CFTR potentiator","Other indication","Cystic fibrosis","cystic fibrosis","MONDO_0009061","Original","Serious",2018,"P, O, B, F",TRUE,2018,FALSE,FALSE,FALSE
"Symproic","Naldemedine","NALDEMEDINE","CHEMBL2105755","ENSG00000112038","Original","Shionogi","Opioid antagonist","Other indication","Opioid-induced constipation","Constipation","HP_0002019","Original","Not serious",2017,"S",FALSE,2017,FALSE,FALSE,FALSE
"TPOXX","Tecovirimat","TECOVIRIMAT","CHEMBL1257073",NA,"Original","SIGA Technologies","Viral p37 protein inhibitor","No human target","Smallpox","smallpox","MONDO_0004651","Original","Serious",2018,"P, O, F",NA,NA,NA,NA,NA
"Tabrecta","Capmatinib","CAPMATINIB","CHEMBL3188267","ENSG00000105976","Original","Novartis","MET kinase inhibitor","Oncology","NSCLC","non-small cell lung carcinoma","EFO_0003060","Original","Serious",2020,"P, O, B, A",TRUE,2020,FALSE,FALSE,FALSE
"Tafinlar","Dabrafenib","DABRAFENIB","CHEMBL2028663","ENSG00000157764","Original","GSK","Kinase inhibitor with activity against BRAFV600E, BRAFV600K, BRAFV600D, wild-type BRAF and other kinases","Oncology","Unresectable or metastatic melanoma with BRAF(V600E) mutation as detected by an FDA-approved test","metastatic melanoma","EFO_0002617","Original","Serious",2013,"S, O, F",TRUE,2013,FALSE,TRUE,FALSE
"Tagrisso","Osimertinib","OSIMERTINIB","CHEMBL3353410","ENSG00000146648","Original","AstraZeneca","EGFR inhibitor","Oncology","NSCLC with EGFRT790M mutations","non-small cell lung carcinoma","EFO_0003060","Original","Serious",2015,"P, O, B, A, F",TRUE,2015,FALSE,FALSE,FALSE
"Takhzyro","Lanadelumab","LANADELUMAB","CHEMBL3545189","ENSG00000164344","Original","Dyax/Shire","Kallikrein antibody","Other indication","Hereditary angioedema","hereditary angioedema","MONDO_0019623","Original","Serious",2018,"P, O, B, F",FALSE,2018,FALSE,FALSE,FALSE
"Taltz","Ixekizumab","IXEKIZUMAB","CHEMBL1743034","ENSG00000112115","Original","Eli Lilly","IL-17A antagonist","Other indication","Plaque psoriasis","psoriasis vulgaris","EFO_1001494","Original","Not serious",2016,"S",FALSE,2016,FALSE,FALSE,FALSE
"Talzenna","Talazoparib","TALAZOPARIB","CHEMBL3137320","ENSG00000143799, ENSG00000129484","Original","Pfizer","PARP inhibitor","Oncology","BRCA-mutated HER2-negative breast cancer","HER2 negative breast carcinoma","EFO_0009780","Original","Serious",2018,"P",TRUE,2018,TRUE,TRUE,FALSE
"Tanzeum","Albiglutide","ALBIGLUTIDE","CHEMBL2107841","ENSG00000112164","Original","GlaxoSmithKline","GLP1-receptor agonist","Other indication","Type 2 diabetes","type 2 diabetes mellitus","MONDO_0005148","Original","Not concordant",2014,"S",TRUE,2014,FALSE,FALSE,FALSE
"Tavalisse","Fostamatinib","FOSTAMATINIB","CHEMBL2103830","ENSG00000165025","Original","Rigel Pharmaceuticals","SYK inhibitor","Other indication","Immune thrombocytopenic purpura","autoimmune thrombocytopenic purpura","EFO_0007160","Original","Serious",2018,"S, O",TRUE,2018,TRUE,FALSE,FALSE
"Tavneos","Avacopan","Avacopan","CHEMBL3989871","ENSG00000197405","Original","ChemoCentryx","Complement 5a receptor antagonist","Other indication","ANCA-associated vasculitis","Anti-neutrophil cytoplasmic antibody-associated vasculitis","MONDO_0015492","Original","Serious",2021,"S, O",FALSE,2021,FALSE,FALSE,FALSE
"Tazverik","Tazemetostat","TAZEMETOSTAT","CHEMBL3414621","ENSG00000106462","Original","Epizyme","EZH2 inhibitor","Oncology","Epithelioid sarcoma","epithelioid sarcoma","MONDO_0017387","Original","Serious",2020,"P, O, A, F",TRUE,2020,FALSE,TRUE,FALSE
"Tecentriq","Atezolizumab","ATEZOLIZUMAB","CHEMBL3707227","ENSG00000120217","Original","Genentech","PDL1 inhibitor","Oncology","Urothelial carcinoma","urothelial carcinoma","EFO_0008528","Original","Serious",2016,"P, B, A",TRUE,2016,FALSE,FALSE,FALSE
"Tecfidera","Dimethyl fumarate","DIMETHYL FUMARATE","CHEMBL2107333","ENSG00000079999","Original","Biogen Idec","MOA unknown; activates NRF2 pathway","Other indication","Relapsing forms of multiple sclerosis","relapsing-remitting multiple sclerosis","EFO_0003929","Original","Serious",2013,"S",TRUE,2013,FALSE,TRUE,FALSE
"Tecvayli","Teclistamab","Teclistamab","CHEMBL4594505","ENSG00000048462, ENSG00000160654, ENSG00000198851, ENSG00000167286","Original","J&J","BCMA _ CD3 bispecific antibody","Oncology","Multiple myeloma","multiple myeloma","EFO_0001378","Original","Serious",2022,"P, O, B, A",TRUE,2022,TRUE,TRUE,TRUE
"Tegsedi","Inotersen","INOTERSEN","CHEMBL4297770","ENSG00000118271","Original","Ionis Pharmaceuticals","TTR-directed antisense oligonucleotide","Other indication","Hereditary TTR-mediated amyloidosis","hereditary ATTR amyloidosis","MONDO_0017132","Original","Serious",2018,"P, O, F",TRUE,2018,FALSE,FALSE,FALSE
"Tepezza","Teprotumumab","TEPROTUMUMAB","CHEMBL1743079","ENSG00000140443","Original","Horizon Therapeutics","IGF1R-directed mAb","Other indication","Thyroid eye disease","Graves disease","EFO_0004237","Original","Not concordant",2020,"P, O, B, F",FALSE,2020,FALSE,FALSE,FALSE
"Tepmetko","Tepotinib","Tepotinib","CHEMBL3402762","ENSG00000105976","Original","EMD Serono","MET kinase inhibitor","Oncology","NSCLC","non-small cell lung carcinoma","EFO_0003060","Original","Serious",2021,"P, O, A",TRUE,2021,FALSE,FALSE,FALSE
"Terlivaz","Terlipressin","Terlipressin","CHEMBL2135460","ENSG00000166148","Original","Mallinckrodt","Vasopressin receptor agonist","Other indication","Kidney function in hepatorenal syndrome","Hepatorenal syndrome","MONDO_0001382","Original","Serious",2022,"P, O, F",FALSE,2022,FALSE,FALSE,FALSE
"Tezspire","Tezepelumab","Tezepelumab","CHEMBL3707229","ENSG00000145777","Original","Astrazeneca/Amgen","TSLP-targeted mAb","Other indication","Serious asthma","asthma","MONDO_0004979","Original","Serious",2021,"P",TRUE,2021,FALSE,FALSE,FALSE
"Tibsovo","Ivosidenib","IVOSIDENIB","CHEMBL3989958","ENSG00000138413","Original","Agios Pharmaceuticals","IDH1 inhibitor","Oncology","IDH1-mutated AML, Locally Advanced or Metastatic Cholangiocarcinoma (*)","acute myeloid leukemia; cholangiocarcinoma","EFO_0000222; EFO_0005221","Original","Serious",2018,"P, O, F",TRUE,2018,FALSE,FALSE,FALSE
"Tissueblue","Brilliant Blue G","BRILLIANT BLUE G","CHEMBL4173394",NA,"Original","Dutch Ophthalmic Research","Brilliant Blue G dye","No human target","Staining the internal limiting membrane",NA,NA,"Original",NA,2019,"P, O",NA,NA,NA,NA,NA
"Tivdak","Tisotumab vedotin","Tisotumab vedotin","CHEMBL4297841","ENSG00000117525, ENSG00000167552, ENSG00000258947, ENSG00000137267, ENSG00000188229, ENSG00000176014, ENSG00000261456, ENSG00000123416, ENSG00000198033, ENSG00000196230, ENSG00000167553, ENSG00000152086, ENSG00000104833, ENSG00000137285, ENSG00000101162, ENSG00000127824","Original","Seagen/Genmab","Tissue-factor-directed ADC","Oncology","Cervical cancer","cervical cancer","MONDO_0002974","Original","Serious",2021,"P, A",TRUE,2021,TRUE,FALSE,FALSE
"Tivicay","Dolutegravir","DOLUTEGRAVIR","CHEMBL1229211",NA,"Original","ViiV","HIV1 integrase strand transfer inhibitor","No human target","HIV1 infection in adults and children, in combination with other antiretroviral agents","HIV infection","EFO_0000764","Original","Serious",2013,"P, F",NA,NA,NA,NA,NA
"Tremfya","Guselkumab","GUSELKUMAB","CHEMBL2364648","ENSG00000113302, ENSG00000110944","Original","Janssen/Johnson & Johnson","IL-23 blocker","Other indication","Plaque psoriasis","psoriasis vulgaris","EFO_1001494","Original","Not serious",2017,"P",TRUE,2017,FALSE,FALSE,FALSE
"Tresiba","Insulin degludec","INSULIN DEGLUDEC","CHEMBL2107869","ENSG00000171105","Original","Novo Nordisk","Long-acting insulin","Other indication","Diabetes","diabetes mellitus","EFO_0000400","Original","Not concordant",2015,"S",TRUE,2015,FALSE,FALSE,FALSE
"Trikafta","Tezacaftor; elexacaftor; ivacaftor","TEZACAFTOR; ELEXACAFTOR; IVACAFTOR","CHEMBL3544914; CHEMBL4298128; CHEMBL2010601","ENSG00000001626; ENSG00000001626; ENSG00000001626","Original","Vertex","Two CFTR correctors and a CFTR potentiator","Other indication","Most common gene mutation that causes cystic fibrosis","cystic fibrosis","MONDO_0009061","Original","Serious",2019,"P, O, B, F",TRUE,2019,FALSE,FALSE,FALSE
"Trodelvy","Sacituzumab govitecan","SACITUZUMAB GOVITECAN","CHEMBL3545262","ENSG00000198900, ENSG00000184292","Original","Immunomedics/Gilead","TROP2-directed ADC, with topoisomerase inhibitor","Oncology","Triple-negative breast cancer (and advanced or metastatic urothelial cancer (mUC)*)","triple-negative breast cancer; urothelial carcinoma","EFO_0005537; EFO_0008528","Original","Serious",2020,"P, B, A, F",TRUE,2020,FALSE,FALSE,FALSE
"Trogarzo","Ibalizumab","IBALIZUMAB","CHEMBL1743029","ENSG00000010610","Original","TaiMed Biologics/Theratechnologies","CD4 antibody","Other indication","HIV","hiv infection","EFO_0000764","Original","Serious",2018,"P, O, B, F",TRUE,2018,TRUE,FALSE,FALSE
"Trulance","Plecanatide","PLECANATIDE","CHEMBL2103867","ENSG00000070019","Original","Synergy Pharmaceuticals","Guanylate cyclase C agonist","Other indication","Chronic idiopathic constipation","Chronic constipation","HP_0012450","Original","Not serious",2017,"S",FALSE,2017,FALSE,FALSE,FALSE
"Trulicity","Dulaglutide","DULAGLUTIDE","CHEMBL2108027","ENSG00000112164","Original","Eli Lilly","GLP1-receptor agonist","Other indication","Type 2 diabetes","type 2 diabetes mellitus","MONDO_0005148","Original","Not concordant",2014,"S",TRUE,2014,FALSE,FALSE,FALSE
"Truseltiq","Infigratinib","Infigratinib","CHEMBL1852688","ENSG00000160867, ENSG00000068078, ENSG00000066468, ENSG00000077782","Original","BridgeBio","FGFR2 kinase inhibitor","Oncology","FGFR2-mutated bile duct cancer","bile duct cancer","MONDO_0003059","Original","Serious",2021,"P, O, A, F",TRUE,2021,FALSE,FALSE,FALSE
"Tukysa","Tucatinib","TUCATINIB","CHEMBL3989868","ENSG00000141736","Original","Seagen","HER2 kinase inhibitor","Oncology","HER2-positive breast cancer","HER2 Positive Breast Carcinoma","EFO_1000294","Original","Serious",2020,"P, O, B, F",TRUE,2020,FALSE,FALSE,FALSE
"Turalio","Pexidartinib","PEXIDARTINIB","CHEMBL3813873","ENSG00000182578, ENSG00000122025, ENSG00000157404","Original","Daiichi Sankyo","CSF1R, KIT and FLT3 inhibitor","Oncology","Tenosynovial giant cell tumour","Tenosynovial Giant Cell Tumor","EFO_1000562","Original","Serious",2019,"P, O, B",TRUE,2019,FALSE,TRUE,FALSE
"Tymlos","Abaloparatide","ABALOPARATIDE","CHEMBL3301581","ENSG00000160801","Original","Radius Health","Parathyroid hormone-related protein","Other indication","Osteoporosis","osteoporosis","EFO_0003882","Original","Not serious",2017,"S",TRUE,2017,TRUE,FALSE,FALSE
"Tzield","Teplizumab","Teplizumab","CHEMBL1743078","ENSG00000198851","Original","Provention Bio","CD3-targeted antibody","Other indication","Delay onset of type 1 diabetes","type 1 diabetes mellitus","MONDO_0005147","Original","Not concordant",2022,"P, B",TRUE,2022,TRUE,FALSE,FALSE
"Ubrelvy","Ubrogepant","UBROGEPANT","CHEMBL2364638","ENSG00000064989","Original","Allergan","CGRP receptor antagonist","Other indication","Migraine with or without aura","migraine disorder","MONDO_0005277","Original","Not serious",2019,"S",TRUE,2019,TRUE,FALSE,FALSE
"Ukoniq","Umbralisib","Umbralisib","CHEMBL3948730","ENSG00000171608, ENSG00000097007, ENSG00000213923","Original","TG Therapeutics","PI3Kdelta and CK1epsilon inhibitor","Oncology","MZL, follicular lymphoma","MZL; follicular lymphoma","EFO_1000630; MONDO_0018906","Original","Serious",2021,"P, O, B, A",TRUE,2021,TRUE,TRUE,TRUE
"Ultomiris","Ravulizumab","RAVULIZUMAB","CHEMBL3989986","ENSG00000106804","Original","Alexion","Complement inhibitor","Other indication","Paroxysmal nocturnal haemoglobinuria, atypical hemolytic uremic syndrome (*), generalized myasthenia gravis AChR+ (*)","paroxysmal nocturnal hemoglobinuria, atypical hemolytic-uremic syndrome, Myasthenia gravis","MONDO_0100244; MONDO_0016244; EFO_0004991","Original","Serious",2018,"S, O",TRUE,2018,TRUE,TRUE,FALSE
"Unituxin","Dinutuximab","DINUTUXIMAB","CHEMBL3137342",NA,"Original","United Therapeutics","GD2-binding mAb",NA,"Neuroblastoma","neuroblastoma","EFO_0000621","Original","Serious",2015,"P, O",NA,NA,NA,NA,NA
"Uplizna","Inebilizumab","INEBILIZUMAB","CHEMBL2109334","ENSG00000177455","Original","Viela Bio","CD19-directed mAb","Other indication","NMOSD","neuromyelitis optica","EFO_0004256","Original","Serious",2020,"S, O, B",FALSE,2020,FALSE,FALSE,FALSE
"Uptravi","Selexipag","SELEXIPAG","CHEMBL238804","ENSG00000160013","Original","Actelion","Prostacyclin receptor agonist","Other indication","Pulmonary arterial hypertension","pulmonary arterial hypertension","EFO_0001361","Original","Serious",2015,"S, O",FALSE,2015,FALSE,FALSE,FALSE
"Vabomere","Meropenem; vaborbactam","MEROPENEM; VABORBACTAM","CHEMBL127; CHEMBL3317857","NA; NA","Original","The Medicines Company/Rempex Pharmaceuticals","Carbapenem antimicrobial plus a ‚Äö√¢√†‚àö‚â†‚Äö√Ñ√∂‚àö¬¢¬¨√ü-lactamase inhibitor","No human target","Complicated urinary tract infections","urinary tract infection","EFO_0003103","Original","Not serious",2017,"P, F",NA,NA,NA,NA,NA
"Vabysmo","Faricimab","Faricimab","CHEMBL4297750","ENSG00000112715, ENSG00000091879","Original","Roche/Genentech","VEGF _ ANG2 bispecific antibody","Other indication","nAMD and DME","age-related macular degeneration","EFO_0001365","Original","Not serious",2022,"S",TRUE,2022,FALSE,FALSE,FALSE
"Varubi","Rolapitant","ROLAPITANT","CHEMBL3707331","ENSG00000115353","Original","Tesaro","Neurokinin 1 receptor antagonist","Other indication","Nausea and vomiting associated with chemotherapy","Chemotherapy-induced nausea and vomiting","EFO_0006911","Original","Not serious",2015,"S",FALSE,2015,FALSE,FALSE,FALSE
"Veklury","Remdesivir","REMDESIVIR","CHEMBL4065616",NA,"Original","Gilead","Nucleotide analogue RNA polymerase inhibitor","No human target","COVID-19","covid-19","MONDO_0100096","Original","Serious",2020,"P, F",NA,NA,NA,NA,NA
"Veltassa","Patiromer sorbitex","PATIROMER SORBITEX","CHEMBL2107840",NA,"Original","Relypsa","Potassium binder","No human target","Hyperkalaemia","Hyperkalemia","HP_0002153","Original","Not concordant",2015,"S",NA,NA,NA,NA,NA
"Venclexta","Venetoclax","VENETOCLAX","CHEMBL3137309","ENSG00000171791","Original","AbbVie","BCL-2 inhibitor","Oncology","Chronic lymphocytic leukaemia","chronic lymphocytic leukemia","EFO_0000095","Original","Serious",2016,"P, O, B, A",TRUE,2016,FALSE,FALSE,FALSE
"Verquvo","Vericiguat","Vericiguat","CHEMBL4066936","ENSG00000123201, ENSG00000061918, ENSG00000152402, ENSG00000164116","Original","Merck & Co./Bayer","sGC stimulator","Other indication","Chronic heart failure","coronary artery disease","EFO_0001645","Original","Serious",2021,"P, F",TRUE,2021,FALSE,FALSE,FALSE
"Verzenio","Abemaciclib","ABEMACICLIB","CHEMBL3301610","ENSG00000105810, ENSG00000135446","Original","Eli Lilly","CDK4/6 inhibitor","Oncology","HR-positive, HER2-negative breast cancer","HER2 negative breast carcinoma","EFO_0009780","Original","Serious",2017,"P, B, F",TRUE,2017,TRUE,TRUE,FALSE
"Viberzi","Eluxadoline","ELUXADOLINE","CHEMBL2159122","ENSG00000112038","Original","Allergan","Mu-opioid receptor agonist","Other indication","Irritable bowel syndrome","irritable bowel syndrome","EFO_0000555","Original","Not serious",2015,"P, F",FALSE,2015,FALSE,FALSE,FALSE
"Viekira Pak","Ombitasvir; paritaprevir; dasabuvir; ritonavir","OMBITASVIR; PARITAPREVIR; DASABUVIR; RITONAVIR","CHEMBL3127326; CHEMBL3391662; CHEMBL3137312; CHEMBL163","NA; NA; NA; ENSG00000021461, ENSG00000160870, ENSG00000106258, ENSG00000160868","Original","AbbVie","An NS5A inhibitor plus an NS3A- and NS4A-protease inhibitor plus a non-nucleoside NS5B-palm-polymerase inhibitor plus a CYP3A inhibitor","Other indication","Chronic HCV genotype 1 infection","hepatitis C virus infection","EFO_0003047","Original","Serious",2014,"P, B, F",NA,2014,FALSE,FALSE,FALSE
"Viltepso","Viltolarsen","VILTOLARSEN","CHEMBL4298062","ENSG00000198947","Original","Nippon Shinyaku","Dystrophin splicing modifier","Other indication","Duchenne muscular dystrophy","duchenne muscular dystrophy","MONDO_0010679","Original","Serious",2020,"P, O, A, F",TRUE,2020,FALSE,FALSE,FALSE
"Vimizim","Elosulfase alfa","ELOSULFASE ALFA","CHEMBL2108676","ENSG00000141012","Original","BioMarin","Hydrolytic lysosomal glycosaminoglycan-specific enzyme","Other indication","Mucopolysaccharidosis type IVA","mucopolysaccharidosis type 4A","MONDO_0009659","Original","Serious",2014,"P, O, F",TRUE,2014,FALSE,FALSE,FALSE
"Vitrakvi","Larotrectinib","LAROTRECTINIB","CHEMBL3889654","ENSG00000148053, ENSG00000198400, ENSG00000140538","Original","Loxo Oncology/Bayer","TRKA, TRKB and TRKC inhibitor","Oncology","NTRK-positive solid cancers","salivary gland cancer; soft tissue sarcoma; thyroid cancer","MONDO_0004669; EFO_1001968; MONDO_0002108","Original","Serious",2018,"P, O, B, A",TRUE,2018,FALSE,FALSE,FALSE
"Vivjoa","Oteseconazole","Oteseconazole","CHEMBL3311228",NA,"Original","Mycovia","Azole antifungal","No human target","Vulvovaginal candidiasis","vulvovaginal candidiasis","EFO_0007543","Original",NA,2022,"P, F",NA,NA,NA,NA,NA
"Vizamyl","Flutemetamol F-18","FLUTEMETAMOL F-18","CHEMBL2042122","ENSG00000142192","Original","GE Healthcare","Radioactive diagnostic agent","Other indication","PET imaging of the brain to estimate beta-amyloid neuritic plaque density in patients who are being evaluated for Alzheimer's disease","neuritic plaque measurement; Alzheimer disease","EFO_0006798; MONDO_0004975","Original","Serious",2013,"S",TRUE,2013,FALSE,FALSE,FALSE
"Vizimpro","Dacomitinib","DACOMITINIB","CHEMBL2105719","ENSG00000178568, ENSG00000146648, ENSG00000141736","Original","Pfizer","EGFR inhibitor","Oncology","EGFR-mutated NSCLC","non-small cell lung carcinoma","EFO_0003060","Original","Serious",2018,"P, O",TRUE,2018,FALSE,FALSE,FALSE
"Vonjo","Pacritinib","Pacritinib","CHEMBL2035187","ENSG00000096968, ENSG00000122025","Original","CTI Biopharma","JAK2 inhibitor","Oncology","Myelofibrosis","myelofibrosis","MONDO_0044903","Original","Serious",2022,"P, O, A, F",TRUE,2022,FALSE,FALSE,FALSE
"Voquezna Triple Pak","Vonoprazan; amoxicillin; clarithromycin","Vonoprazan; amoxicillin; clarithromycin","CHEMBL2079130; CHEMBL1082; CHEMBL1741","ENSG00000186009, ENSG00000105675; NA; NA","Original","Phathom","Potassium-competitive acid blocker plus a penicillin class antibacterial plus a macrolide antimicrobial","Other indication","Helicobacter pylori infection","Helicobacter pylori infectious disease","EFO_1000961","Original","Not serious",2022,"P, F",NA,2022,FALSE,FALSE,FALSE
"Vosevi","Sofosbuvir; velpatasvir; voxilaprevir","SOFOSBUVIR; VELPATASVIR; VOXILAPREVIR","CHEMBL1259059; CHEMBL3545062; CHEMBL3707372","NA; NA; NA","Original","Gilead Sciences","Nucleotide analogue NS5B polymerase inhibitor plus an NS5A inhibitor plus an NS3/4A protease inhibitor","No human target","HCV","hepatitis C virus infection","EFO_0003047","Original","Serious",2017,"P, B",NA,NA,NA,NA,NA
"Voxzogo","Vosoritide","Vosoritide","CHEMBL3707276","ENSG00000159899","Original","Biomarin","CNP analogue","Other indication","Achondroplasia","achondroplasia","MONDO_0007037","Original","Not serious",2021,"P, O, A",TRUE,2021,FALSE,FALSE,FALSE
"Vraylar","Cariprazine","CARIPRAZINE","CHEMBL2028019","ENSG00000151577, ENSG00000149295","Original","Forest","Atypical antipsychotic","Other indication","Schizophrenia and bipolar 1 disorder","Schizophrenia; bipolar disorder","MONDO_0005090; MONDO_0004985","Original","Serious",2015,"S",TRUE,2015,FALSE,FALSE,FALSE
"Vtama","Tapinarof","Tapinarof","CHEMBL259571","ENSG00000106546","Original","Dermavant","Aryl hydrocarbon receptor agonist","Other indication","Plaque psoriasis","psoriasis vulgaris","EFO_1001494","Original","Not serious",2022,"S",TRUE,2022,FALSE,TRUE,FALSE
"Vyepti","Eptinezumab","EPTINEZUMAB","CHEMBL3833320","ENSG00000110680, ENSG00000175868","Original","Lundbeck","CGRP-directed mAb","Other indication","Migraine","migraine disorder","MONDO_0005277","Original","Not serious",2020,"S",TRUE,2020,FALSE,FALSE,FALSE
"Vyleesi","Bremelanotide","BREMELANOTIDE","CHEMBL2070241","ENSG00000166603","Original","Amag","Melanocortin receptor agonist","Other indication","Hypoactive sexual desire disorder","sexual dysfunction","EFO_0004714","Original","Not serious",2019,"S",TRUE,2019,FALSE,TRUE,FALSE
"Vyndaqel","Tafamidis","TAFAMIDIS","CHEMBL2103837","ENSG00000118271","Original","Pfizer/Foldrx","Transthyretin stabilizer","Other indication","Heart disease caused by ATTR-CM","cardiomyopathy","EFO_0000318","Original","Serious",2019,"P, O, B, F",TRUE,2019,FALSE,FALSE,FALSE
"Vyondys 53","Golodirsen","GOLODIRSEN","CHEMBL4297762","ENSG00000198947","Original","Sarepta","Exon 53 skipping antisense","Other indication","Duchenne muscular dystrophy","duchenne muscular dystrophy","MONDO_0010679","Original","Serious",2019,"P, O, A, F",TRUE,2019,FALSE,FALSE,FALSE
"Vyvgart","Efgartigimod alfa","Efgartigimod alfa","CHEMBL4297551","ENSG00000104870","Original","Argenx","FcRn-binding Fc fragment","Other indication","Myasthenia gravis","Myasthenia gravis","EFO_0004991","Original","Serious",2021,"S, O, F",FALSE,2021,FALSE,FALSE,FALSE
"Vyzulta","Latanoprostene bunod","LATANOPROSTENE BUNOD","CHEMBL2364612","ENSG00000122420","Original","Bausch and Lomb/Valeant Pharmaceuticals","Prostaglandin analogue","Other indication","Intraocular pressure","intraocular pressure measurement","EFO_0004695","Original","Not serious",2017,"S",FALSE,2017,FALSE,FALSE,FALSE
"Wakix","Pitolisant","PITOLISANT","CHEMBL462605","ENSG00000101180","Original","Harmony","H3-receptor antagonist/inverse agonist","Other indication","Excessive sleepiness due to narcolepsy","narcolepsy","MONDO_0021107","Original","Serious",2019,"P, O, F",FALSE,2019,FALSE,FALSE,FALSE
"Welireg","Belzutifan","Belzutifan","CHEMBL4585668","ENSG00000116016","Original","Merck & Co.","HIF-2alpha inhibitor","Oncology","von Hippel-Lindau disease","von Hippel-Lindau disease","MONDO_0008667","Original","Serious",2021,"P, O",TRUE,2021,TRUE,TRUE,FALSE
"Winlevi","Clascoterone","CLASCOTERONE","CHEMBL3590187","ENSG00000169083","Original","Cassiopea SpA","Androgen receptor inhibitor","Other indication","Acne vulgaris","acne","EFO_0003894","Original","Not serious",2020,"S",TRUE,2020,TRUE,FALSE,FALSE
"Xadago","Safinamide","SAFINAMIDE","CHEMBL396778","ENSG00000069535","Original","US WorldMeds","MAO-B inhibitor","Other indication","Parkinson disease","Parkinson disease","MONDO_0005180","Original","Serious",2017,"S",TRUE,2017,TRUE,FALSE,FALSE
"Xcopri","Cenobamate","CENOBAMATE","CHEMBL3989949","ENSG00000168356, ENSG00000196876, ENSG00000185313, ENSG00000144285, ENSG00000153253, ENSG00000183873, ENSG00000136531, ENSG00000169432, ENSG00000136546, ENSG00000007314, ENSG00000186297, ENSG00000151834, ENSG00000011677, ENSG00000187730, ENSG00000109158, ENSG00000022355, ENSG00000166206, ENSG00000182256, ENSG00000145864, ENSG00000268089, ENSG00000145863, ENSG00000094755, ENSG00000163288, ENSG00000113327, ENSG00000102287, ENSG00000163285","Original","SK Life Science","Unknown","Other indication","Partial onset seizures","seizure","HP_0001250","Original","Not concordant",2019,"S",TRUE,2019,FALSE,FALSE,FALSE
"Xeglyze","Abametapir","ABAMETAPIR","CHEMBL2205807",NA,"Original","Dr Reddy‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚àö√´‚Äö√†√∂‚Äö√†√á‚Äö√Ñ√∂‚àö‚Ä†‚àö‚àÇ‚Äö√†√∂‚àö¬¥‚Äö√Ñ√∂‚àö‚Ä†‚àö‚àÇ¬¨¬®‚Äö√Ñ¬¢s","Metalloproteinase inhibitor","No human target","Head lice","lice infestation","MONDO_0003472","Original","Not serious",2020,"S",NA,NA,NA,NA,NA
"Xenleta","Lefamulin","LEFAMULIN","CHEMBL3291398",NA,"Original","Nabriva","Pleuromutilin antibacterial","No human target","CABP","bacterial pneumonia","EFO_1001272","Original","Serious",2019,"P, F",NA,NA,NA,NA,NA
"Xenoview","Xenon Xe 129 hyperpolarized","Xenon Xe 129 hyperpolarized","CHEMBL4594411",NA,"Original","Polarean","Hyperpolarized contrast agent","No human target","MRI-evaluation of lung ventilation",NA,NA,"Original",NA,2022,"S",NA,NA,NA,NA,NA
"Xenpozyme","Olipudase alfa","Olipudase alfa","CHEMBL3707358","ENSG00000166311","Original","Sanofi/Genzyme","Acid sphingomyelinase ERT","Other indication","Acid sphingomyelinase deficiency","acid sphingomyelinase deficiency","MONDO_0100464","Original","Serious",2022,"P, O, B, F",TRUE,2022,FALSE,FALSE,FALSE
"Xepi","Ozenoxacin","OZENOXACIN","CHEMBL3990047",NA,"Original","Ferrer Internacional","Quinolone antimicrobial","No human target","Impetigo due to Staphylococcus aureus or Streptococcus pyogenes","impetigo","EFO_1000714","Original","Not serious",2017,"S",NA,NA,NA,NA,NA
"Xerava","Eravacycline","ERAVACYCLINE","CHEMBL1951095",NA,"Original","Tetraphase Pharmaceuticals","Tetracycline antibiotic","No human target","Complicated intra-abdominal infections","infectious disease","EFO_0005741","Original","Serious",2018,"P, F",NA,NA,NA,NA,NA
"Xermelo","Telotristat etiprate","TELOTRISTAT ETIPRATE","CHEMBL3348963","ENSG00000129167, ENSG00000139287","Original","Lexicon Pharmaceuticals","Tryptophan hydroxylase inhibitor","Other indication","Carcinoid syndrome diarrhoea","carcinoid syndrome; Diarrhea","EFO_1000852; HP_0002014","Original","Not serious",2017,"P, O, F",FALSE,2017,FALSE,FALSE,FALSE
"Xiidra","Lifitegrast","LIFITEGRAST","CHEMBL2048028","ENSG00000160255, ENSG00000005844","Original","Shire Pharmaceuticals","LFA1 antagonist","Other indication","Dry eye disease","dry eye syndrome","EFO_1000906","Original","Not serious",2016,"P",FALSE,2016,FALSE,FALSE,FALSE
"Xofigo","Radium RA 223 dichloride","RADIUM RA 223 DICHLORIDE","CHEMBL2107816",NA,"Original","Bayer","Alpha particle-emitting radioactive therapeutic","No human target","Castration-resistant prostate cancer","prostate cancer","MONDO_0008315","Original","Serious",2013,"P, F",NA,NA,NA,NA,NA
"Xofluza","Baloxavir marboxil","BALOXAVIR MARBOXIL","CHEMBL4297503",NA,"Original","Shionogi/Roche","Polymerase acidic endonuclease inhibitor","No human target","Acute uncomplicated influenza","influenza","EFO_0007328","Original","Not serious",2018,"P",NA,NA,NA,NA,NA
"Xospata","Gilteritinib","GILTERITINIB","CHEMBL3301622","ENSG00000122025, ENSG00000167601","Original","Astellas","FLT3 inhibitor","Oncology","FLT3-positive AML","acute myeloid leukemia","EFO_0000222","Original","Serious",2018,"P, O, B, F",TRUE,2018,FALSE,FALSE,FALSE
"Xpovio","Selinexor","SELINEXOR","CHEMBL3545185","ENSG00000082898","Original","Karyopharm Therapeutics","XPO1 inhibitor","Oncology","Multiple myeloma","multiple myeloma","EFO_0001378","Original","Serious",2019,"P, O, A, F",TRUE,2019,FALSE,FALSE,FALSE
"Xtoro","Finafloxacin","FINAFLOXACIN","CHEMBL1908370",NA,"Original","Alcon","Fluoroquinolone antimicrobial","No human target","Acute otitis externa (swimmer's ear)","otitis externa","EFO_0009560","Original","Not serious",2014,"P",NA,NA,NA,NA,NA
"Xuriden","Uridine","URIDINE","CHEMBL100259",NA,"Original","Wellstat","Pyrimidine analogue","No human target","Hereditary orotic aciduria","Hereditary orotic aciduria","Orphanet_30","Original","Serious",2015,"P, O, B",NA,NA,NA,NA,NA
"Yondelis","Trabectedin","TRABECTEDIN","CHEMBL450449",NA,"Original","Johnson & Johnson","Alkylating drug",NA,"Liposarcoma or leiomyosarcoma","liposarcoma; leiomyosarcoma","EFO_0000569; EFO_0000564","Original","Serious",2015,"P, O",NA,NA,NA,NA,NA
"Yupelri","Revefenacin","REVEFENACIN","CHEMBL3833319","ENSG00000133019","Original","Theravance Biopharma/Mylan","Long-acting muscarinic receptor antagonist","Other indication","COPD","chronic obstructive pulmonary disease","EFO_0000341","Original","Serious",2018,"S",TRUE,2018,FALSE,FALSE,FALSE
"Zegalogue","Dasiglucagon","Dasiglucagon","CHEMBL4297741","ENSG00000215644","Original","Zealand Pharma","Glucagon receptor agonist","Other indication","Serious hypoglycaemia","GCGR-related hyperglucagonemia","EFO_0001360","Original","Serious",2021,"S",FALSE,2021,FALSE,FALSE,FALSE
"Zejula","Niraparib","NIRAPARIB","CHEMBL1094636","ENSG00000129484, ENSG00000143799","Original","Tesaro","PARP inhibitor","Oncology","Epithelial ovarian, fallopian tube or primary peritoneal cancer","fallopian tube cancer; ovarian epithelial tumor; primary peritoneal carcinoma","MONDO_0002158; MONDO_0002229; MONDO_0015686","Original","Serious",2017,"P, O, B, F",TRUE,2017,TRUE,FALSE,FALSE
"Zemdri","Plazomicin","PLAZOMICIN","CHEMBL1650559",NA,"Original","Achaogen","Aminoglycoside antibacterial","No human target","Urinary tract infections","urinary tract infection","EFO_0003103","Original","Not serious",2018,"P",NA,NA,NA,NA,NA
"Zepatier","Elbasvir; grazoprevir","ELBASVIR; GRAZOPREVIR","CHEMBL3039514; CHEMBL2063090","NA; NA","Original","Merck & Co.","NS5A inhibitor plus NS3/4A protease inhibitor","No human target","HCV genotypes 1 and 4","hepatitis C virus infection","EFO_0003047","Original","Serious",2016,"P, B",NA,NA,NA,NA,NA
"Zeposia","Ozanimod","OZANIMOD","CHEMBL3707247","ENSG00000170989","Original","Celgene/Bristol Myers Squibb","S1P receptor modulator","Other indication","Multiple sclerosis","multiple sclerosis","MONDO_0005301","Original","Serious",2020,"S",TRUE,2020,TRUE,FALSE,FALSE
"Zepzelca","Lurbinectedin","LURBINECTEDIN","CHEMBL4297516",NA,"Original","Jazz","Alkylating drug",NA,"Small-cell lung cancer","small cell lung carcinoma","EFO_0000702","Original","Serious",2020,"P, O, A",NA,NA,NA,NA,NA
"Zerbaxa","Ceftolozane; tazobactam","CEFTOLOZANE; TAZOBACTAM","CHEMBL2103872; CHEMBL404","NA; NA","Original","Cubist","A cephalosporin antibacterial plus a beta-lactamase inhibitor","No human target","Complicated intra-abdominal infections and complicated urinary tract infections","infection","EFO_0000544","Original","Serious",2014,"P, F",NA,NA,NA,NA,NA
"Zinbryta","Daclizumab","DACLIZUMAB","CHEMBL1201605","ENSG00000134460, ENSG00000100385, ENSG00000147168","Original","Biogen","IL-2-targeted mAb","Other indication","Multiple sclerosis","multiple sclerosis","MONDO_0005301","Original","Serious",2016,"S",TRUE,2016,FALSE,FALSE,FALSE
"Zinplava","Bezlotoxumab","BEZLOTOXUMAB","CHEMBL2108670",NA,"Original","Merck & Co.","mAb against Clostridium difficile toxin","No human target","C. difficile recurrence","clostridium difficile infection","EFO_0009130","Original","Serious",2016,"P, F",NA,NA,NA,NA,NA
"Zokinvy","Lonafarnib","LONAFARNIB","CHEMBL298734","ENSG00000257365, ENSG00000168522","Original","Eiger","Farnesyltransferase inhibitor","Other indication","HGPS","hutchinson-gilford progeria syndrome","MONDO_0008310","Original","Serious",2020,"P, O, B",FALSE,2020,FALSE,FALSE,FALSE
"Zontivity","Vorapaxar","VORAPAXAR","CHEMBL493982","ENSG00000181104","Original","Merck & Co.","Protease-activated receptor 1 antagonist","Other indication","Thrombotic cardiovascular events (after myocardial infarction or with peripheral arterial disease*)","myocardial infarction; peripheral arterial disease","EFO_0000612; EFO_0004265","Original","Serious",2014,"S, F",FALSE,2014,FALSE,FALSE,FALSE
"Ztalmy","Ganaxolone","Ganaxolone","CHEMBL1568698","ENSG00000094755, ENSG00000163288, ENSG00000102287, ENSG00000166206, ENSG00000145863, ENSG00000022355, ENSG00000113327, ENSG00000187730, ENSG00000011677, ENSG00000268089, ENSG00000145864, ENSG00000151834, ENSG00000186297, ENSG00000182256, ENSG00000109158, ENSG00000163285","Original","Marinus","GABAA receptor positive allosteric modulator","Other indication","Seizures associated with CDD","Epileptic encephalopathy","HP_0200134","Original","Serious",2022,"P, O",TRUE,2022,FALSE,FALSE,FALSE
"Zulresso","Brexanolone","BREXANOLONE","CHEMBL207538","ENSG00000094755, ENSG00000109158, ENSG00000186297, ENSG00000022355, ENSG00000145864, ENSG00000166206, ENSG00000182256, ENSG00000011677, ENSG00000268089, ENSG00000102287, ENSG00000113327, ENSG00000163285, ENSG00000151834, ENSG00000145863, ENSG00000163288, ENSG00000187730","Original","Sage Therapeutics","GABAA-receptor-positive modulator","Other indication","Postpartum depression","postpartum depression","EFO_0007453","Original","Not concordant",2019,"P, B",TRUE,2019,FALSE,TRUE,FALSE
"Zurampic","Lesinurad","LESINURAD","CHEMBL2105720","ENSG00000197891","Original","AstraZeneca","URAT1 inhibitor","Other indication","Gout","gout","EFO_0004274","Original","Not serious",2015,"S",TRUE,2015,FALSE,FALSE,FALSE
"Zydelig","Idelalisib","IDELALISIB","CHEMBL2216870","ENSG00000171608","Original","Gilead Sciences","PI3K‚Äöp110-delta subunit inhibitor","Other indication","CLL, B-cell non-Hodgkin lymphoma and SLL","chronic lymphocytic leukemia; B-cell non-Hodgkins lymphoma","EFO_0000095; EFO_1001938","Original","Serious",2014,"P, O, B, A, F",TRUE,2014,FALSE,FALSE,FALSE
"Zykadia","Ceritinib","CERITINIB","CHEMBL2403108","ENSG00000171094, ENSG00000143924, ENSG00000181163","Original","Novartis","Kinase inhibitor against ALK, IGF1R, insulin receptor and ROS1","Oncology","ALK-positive metastatic NSCLC","non-small cell lung carcinoma","EFO_0003060","Original","Serious",2014,"P, O, B, A",TRUE,2014,FALSE,FALSE,FALSE
"Zynlonta","Loncastuximab tesirine","Loncastuximab tesirine","CHEMBL4297778","ENSG00000177455","Original","ADC Therapeutics","CD19-targeted ADC","Oncology","B-cell lymphoma","B-cell non-Hodgkins lymphoma","EFO_1001938","Original","Serious",2021,"P, O, A",TRUE,2021,FALSE,FALSE,FALSE
